Page 4«..3456..1020..»

Healthcare Shopping: The new age of consumerism – The Financial Express

§ July 6th, 2020 § Filed under Quantum Computer Comments Off on Healthcare Shopping: The new age of consumerism – The Financial Express

By Lalit Dash

Srishti, a 35-year-old HR professional, recently started experiencing palpitations and shortness of breath. While looking up on the Internet for information on the probable causes of her condition, she found an online health services platform where she could review portfolios of doctors and treatment options allowing her to shop for the best care provider and a treatment plan at a cost she could afford. Booking and paying for the appointment through the hospitals web interface made it easy for her to schedule the visit as per her convenience.

Post consultation she explored online pharmacies and got her medicine at the best rate, earning some loyalty points in the process. Srishtis situation could be ours. With the onset of digital transformation, the healthcare sector is witnessing a major overhaul. Today, an individual is not just a prospective patient, but a customer armed with a shopping list to select the best doctors, facilities and treatment at an affordable cost and at a time and location of her choice. The flow of information is no longer unidirectional (caregiver to care receiver) but bidirectional and consumer choices are made within and outside the clinical environment. This has led to the healthcare system to leapfrog from a legacy PDS (Public Distribution System) model to a supermarket model.

With an increased focus on the quality of consumer experience, healthcare companies are deploying technologies to make care delivery more accessible and personalised. Medical diagnostics, Internet of Medical Things (IoMT), Blockchain, Artificial Intelligence (AI) and data analytics are triggering disruptive innovations that are, in turn, redefining care paradigms.

Technology, as is evident, is a crucial cog in the evolution of consumerism in healthcare. Innovations in cloud computing, mobility solutions, telemedicine, and quantum computing are making their way into mainstream health operations. For instance, AI and ML are pushing this change through algorithms built for diagnostics of chronic diseases. Augmented reality/virtual reality (AR/VR)-led technology is already being put to use to set up virtual care systems that enable doctors to conduct surgeries in remote areas or during times of a public health emergency.

Natural Language Processing (NLP) technology a form of AI that enables computer programs to process and analyse unstructured data from different sources is extensively being used in technical documentation, leading to a faster diagnosis. Additionally, the gamification of healthcare particularly in-patient wellness is enhancing the customer (vs. patient) mindset and reciprocal engagement. Take for instance, mobile apps that run a rewards program for people who accomplish a health-related task every day or those that encourage participation of friends and family in fitness contests.

With the care providers focus shifting more towards value across customer lifecycle, there will be stronger collaboration between healthcare providers and customers for pre-, during- and post-care medical services. As healthcare consumerism continues to grow, healthcare providers will have to learn to adapt to this changing environment to guide and engage consumer as well as secure their loyalty. This will eventually lead to ease in access to care, reduced cost of care and enhanced quality of care benefitting many consumers such as Srishti.

The writer is senior director Technology, Optum Global Solutions

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know markets Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

See the original post:

Healthcare Shopping: The new age of consumerism - The Financial Express

Read the Rest...

Hundreds Of Scientists Say Coronavirus Is Airborne And The WHO Is Dragging Its Feet Conceding – IFLScience

§ July 6th, 2020 § Filed under Nano Medicine Comments Off on Hundreds Of Scientists Say Coronavirus Is Airborne And The WHO Is Dragging Its Feet Conceding – IFLScience

Over 230 experts are urging the World Health Organization (WHO) to revisittheir information on whether Covid-19 can be spread through airborne transmission that can lurk in indoor spaces, suggesting their hesitancy to do so is putting people in danger.

The 239 signatories from 32 countries argue the UNs health authority needs to seriously explore the possibility that the disease can also be spread via microscopic particles pumped out by breathing and talking that can linger in indoor spaces, according to a statementby theQueensland University of Technology ahead of publication in the journal Clinical Infectious Diseases.

The WHOcurrently advises Covid-19 spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. However, the international group of scientists says this downplays the risk, and the WHO is dragging its feet when it comes to revising its information.

WHOs credibility is being undermined through a steady drip-drip of confusing messages, including asymptomatic spread, the use of masks, and now airborne transmission, Lawrence Gostin, a professor of global health law at Georgetown University who provides technical assistance to the WHO, told the Washington Post.

Critically, the debate about airborne transmission underpins many of the worlds public health strategies. For example, if the novel coronavirus truly is viable in its aerosolized airborne form, it would mean thatpoorly ventilated spaces including workplace environments, schools, restaurants, buses, trains, etc could still be potentiallydangerous, even if peoplestick to a 2-metersocial distancing rule.

Studies by the signatories and other scientists have demonstrated beyond any reasonable doubt that viruses are exhaled in microdroplets small enough to remain aloft in the air and pose a risk of exposure beyond 1 to 2 meters by an infected person, Professor Lidia Morawska, director of the International Air Quality and Health Laboratory, said in a statement.

Naturally, the WHOs information on the ongoing pandemic has been subject to change when new insights have come to light about the Covid-19.The nature of airborne transmission, however, has remained the subject of long, hot debate between scientists. Some argue Covid-19 is mainly spread by larger droplets of mucus flung out by coughs, spitting, and spluttering. Since these droplets are heavy, they can only remain airborne for a short period before heading towards the ground and theres a relatively low risk of the virus lingering in the air. On the other side of the debate, some argue that there is strong evidence the virus can spread through smaller aerosolized particles. Aerosols, or droplets smaller than 5 microns, can float in the air for notably longer and increases the risk of airborne transmission, especially in a stuffy room.

While the SARS-CoV-2 viruscan live in the air under lab conditions for several hours, some scientists have remained doubtful ofwhether it can remainviable and infectious in this form. However, a number of case studies have shown the contrary. One report suggested though it did not definitively prove that air conditioning may have helped to infect at least nine people with Covid-19 at a restaurant in the Chinese city of Guangzhou.

Nevertheless, the debate is ongoing and, in spite of some evidence, the WHO is sticking to its guns for the meantime.

Especially in the last couple of months, we have been stating several times that we consider airborne transmission as possible but certainly not supported by solid or even clear evidence, Dr Benedetta Allegranzi, the WHOs technical lead of infection prevention and control, was quoted by the New York Times.

Read more:
Hundreds Of Scientists Say Coronavirus Is Airborne And The WHO Is Dragging Its Feet Conceding - IFLScience

Read the Rest...

Factfile: The Endocannabinoid System Control Panel of the Human Body – VolteFace Magazine

§ July 6th, 2020 § Filed under Nano Medicine Comments Off on Factfile: The Endocannabinoid System Control Panel of the Human Body – VolteFace Magazine

Is there really an endocannabinoid system? Yes. Although not currently included in textbooks and science curriculums, the endocannabinoid system (ECS) does exist. Cannabis is a plant that happens to interact with the ECS to cause a range of effects. Since cannabis re-emergence into mainstream health and media, it has been under heavy political pressure from all sides; involving scheduling, classification, patient access, medicinal effects, and safety. Therefore, the following article aims to shed light on the intricate, yet mysterious system that is responsible for orchestrating the effects of cannabis, while also providing useful insight for society.

The bodily systems that receive all the attention in textbooks are the circulatory, digestive, endocrine, integumentary, immune, lymphatic, muscular, nervous, renal, reproductive, respiratory, and skeletal systems. The endocannabinoid (endo-can-na-bin-oid) system is a biological system much like the other twelve systems in the human body. Compared to the discovery of the other systems, the ECS is relatively new, with its discovery only taking place in the 1990s. Scientists were late to the party, as phylogenetic studies (the study of evolutionary relationships) showed that the ECS had evolved over 600 million years prior to its discover and currently exists in all mammals. In fact, the ECS enables the constant balance of physiological processes; which includes pain, inflammation, sleep, learning, memory, energy, metabolism, digestion, reproduction, exercise, stress, thermoregulation, and appetite. In other words, balance is the core function of the ECS, biologically known as homeostasis. How does it manage to do all of this? To answer that, we will first need to introduce the components of the system. Until then, one can imagine the way in which the ECS operates to be synonymous to a complex audio control panel. By being able to finely tune a wide variety of outputs in response to changes in the environment.

The ECS is comprised of three different components that help take care of the aforementioned processes. Whether you have ever taken cannabis or not, these three components are working around the clock to keep physiological processes in check. They include the endocannabinoids, their metabolising enzymes, as well as the cannabinoid receptors. First off, endocannabinoids are the molecules that are naturally synthesised within your body and help control many of the key functions stated earlier. The two endocannabinoids produced in our body are Anandamide and 2-AG. Secondly, the metabolising enzymes help with the degradation of these endocannabinoids after they have fulfilled their purpose. These enzymes are called MAG-L and FAAH. Finally, the cannabinoid receptors are the structures that endocannabinoids and other molecules can bind to and broadly speaking, result in downstream effects. The two cannabinoid receptors in the body are the cannabinoid type-1 (CB1) and cannabinoid type-2 (CB2) receptors. The CB1 receptor is found in large concentrations in the brain and less so throughout the body, whereas the CB2 receptor is found in greater quantities throughout the body and less so in the brain. Collectively, their extensive coverage allows for the diversity of functions the ECS plays a role in. To illustrate this point, below is a microscopic image taken during my studies into the RNA expression of the cnr1 gene in mouse models. Depicted is a mouse brain slice that has been prepared and stained for the cnr1 gene (red), which is responsible for producing the CB1 receptor. The red dots serve as a marker, demonstrating the abundance of CB1 receptors in various areas of the brain.

Besides the endocannabinoids, anandamide and 2-AG, there are other types of cannabinoid molecules. Cannabinoids are classified depending on their source. Ultimately, cannabinoids are either endo-cannabinoids, meaning they are produced within the body or exogenous cannabinoids meaning they are produced outside of the body. Besides the endocannabinoids discussed above, exogenous cannabinoids are further classified as either phytocannabinoids or synthetic cannabinoids. Phytocannabinoid are plant-derived, like those found in cannabis. In fact, a total of 144 unique phytocannabinoids have been isolated from the cannabis plant alone, including the widely known THC and CBD phytocannabinoids. On the other hand, synthetic cannabinoids are those that are produced in a laboratory. Regardless of their source, cannabinoids, in some form or another interact with our cannabinoid receptors.

Each of us has an ECS but the capacity in which that system operates may be different. This is referred to as endocannabinoid tone. This tone can be described as the level of ECS activity. This activity is based on factors such as the extent of endocannabinoid synthesis, enzymatic activity, density of cannabinoid receptors. It also includes environmental factors such as but not limited to stress, exercise, and mood. Therefore, even though ones endocannabinoid tone may vary from year to year or even day to day, this tone is generally unique to each of us. The variability in endocannabinoid tone helps explain the inconsistencies in response people may have to taking cannabinoids, such as those found in cannabis.

So, what exactly do our endocannabinoids do? The endocannabinoids represent brakes to the system. Essentially, they dampen the probability of neurotransmitters getting released and thus taking effect. As you may know, different neurotransmitters such as dopamine, glutamate, noradrenaline, serotonin, GABA, and glutamate all have differing effects. Therefore, based on the type of neurotransmitter whose response was dampened, the resulting effect is also changed. Generally speaking, these can be categorised into either the blocking of an excitatory signal (inhibitory effect) or blocking of an inhibitory signal (excitatory effect). Furthermore, the spatial considerations of where in the brain these neurotransmitters are or are not being released plays further into the variances in effect.

Despite the large efforts of research and development (R&D), as well as clinical trials, regulatory approval of cannabinoid-based treatments are few and far between. Currently, there are four cannabinoid-based medicines approved by the US Food and Drug Administration (FDA). Three of these medications are synthetic cannabinoids indicated for either adult AIDS patients suffering from anorexia related weight loss or adult patients suffering from chemotherapy induced nausea and vomiting. These drugs are synthetic forms of THC; they include Dronabinol (Marinol, Syndros) and Nabilone (Cesamet).

The fourth medicine, demonstrates that cannabinoid-based treatments may not solely be synthetic. As of June 25th, 2018, Epidiolex (Epidyolex) became the first plant-derived cannabinoid drug to be approved by the FDA. Epidiolex is an oral solution of highly purified, plant-derived CBD approved for the treatment of two rare and highly debilitating forms of epilepsy, known as Lennox-Gastaut syndrome (LGS) and Dravet syndrome. After Epidiolex was approved by the FDA, it was classified as a Schedule I drug. This was because cannabis and anything derived from the cannabis plant was considered to be Schedule I. This included CBD, and thus implicated Epidiolex (CBD) into the same classification. Upon examination, Cannabis Schedule I classification was justified based on the high abuse potential and lack of medical value confirmed by standardised, double-blind, randomised control trials. What about Epidiolex? It has demonstrated the medical efficacy to warrant an FDA approval. Therefore, nonclinical and clinical studies were conducted to further investigate its abuse potential. After a few months, the Drug Enforcement Administration (DEA) reclassified Epidiolex as Schedule V, the lowest level due to its established medical use and low abuse potential.

So far, this article has examined some of the science behind the ECS and regulatory approaches to the approval and scheduling of cannabinoid-based medicines. It is time to consider the patients because what value can a treatment truly have without patient access. There is an underlying pattern behind currently approved cannabinoid-based medications. They are last choice treatments, only considered after all other conventional therapies have failed. This has made patient access difficult, even in areas of the world that have legalised medical cannabis. For example, the United Kingdom (UK) maintained the Schedule I classification for Epidiolex, which significantly hindered patient access. Additional factors such as the stigma behind cannabis-derived medicines and lack of understanding behind the mechanisms of CBD have led health care professionals and consultants to feel uneasy when it comes to prescribing these treatments, especially given their scheduling. Fortunately, on June 24th, 2020, the British National Health Service (NHS) also down-scheduled Epidiolex to the lowest level (Schedule V) of controlled substances. This would resolve many of the aforementioned difficulties patients encountered when trying to access this medication. Although this may seem like a simple decision that should have been made long ago, regulatory bodies like the NHS and FDA have legitimate cause for concern.

This can be highlighted through the history of one such drug. As covered earlier, the ECS plays a role in behaviours like feeding and appetite. It is through this same process that cannabinoids like THC bind to the CB1 receptor and cause cravings, commonly known as the munchies. Therefore, researchers theorised that blocking this pathway of the ECS would suppress appetite and lead to weight loss. This led to the innovation of a potential weight loss wonder-drug for obese patients. Clinical trials and research proceeded, demonstrating considerable effects in reducing both appetite and weight in animal and human models. In 2006, Europe approved Rimonabant while the FDA remained concerned about its safety profile. Two years later, it was removed from market. It was found that the antagonistic effects on the CB1 receptor not only reduced appetite but also modified other processes and functions. This led to the incidence of negative psychoactive side effects, such as depression and suicidal ideation being associated with the use of Rimonabant. With regards to the ECS-control panel example, while attempting to block or reduce the effects of one switch in the system, many other switches were also affected which throws the endocannabinoid system out of balance. Due to the complexity of the ECS, it is incredibly difficult to achieve desired outcomes without a more fine-tuned approach. This combined with the lack of knowledge regarding the mechanisms of cannabinoid action and long-term safety studies, warrants a careful and comprehensive approach to policy and regulation. Going back to the topic of Epidiolex, at the high doses indicated in such patients, CBD can cause nausea, sedation, and liver toxicity. Therefore, when it comes down to such decisions, it inevitably becomes an evaluation of whether the potential benefits outweigh the potential risks. The evaluation of potential benefits and risks can be extremely difficult, which is why research and clinical trials must continue to deepen our understanding of the endocannabinoid system and how novel molecules can maximise therapeutic benefit.

With that being said, the number of approved cannabinoid-based medicines and products will only continue to rise. Particularly because research and development around the cannabinoid space has been overly active with companies pushing their lead compounds through various stages of the developmental pipeline. In addition, the market is quickly expanding as companies are working to deliver cannabinoids via novel formulations that are more precise and deliberate in their actions. As is usually the case when it comes to dealing with uncertainty, only time will tell.

Read the original here:
Factfile: The Endocannabinoid System Control Panel of the Human Body - VolteFace Magazine

Read the Rest...

Health Matters: Mystery of the diseased toenail | News, Sports, Jobs – Marquette Mining Journal

§ July 6th, 2020 § Filed under Nano Medicine Comments Off on Health Matters: Mystery of the diseased toenail | News, Sports, Jobs – Marquette Mining Journal

Tuesday: Health

Jun 30, 2020

It was a Thursday, another workday at the office. The first patient of the day was new to my practice, but presenting with a common complaint, that of thick, ugly fungal toenails. Do you suffer from such an affliction? Many do. Medically, there was nothing remarkable about this individual. Likewise, her foot health history: unremarkable, just the diseased toenails.

It sounds so simple. Over the last year, this individual had developed two diseased big toenails. They were uncomfortable at times, but never distinctly painful. Initially she had attempted treatment with an over-the-counter fungus medicine but saw little change. Her family doctor had prescribed a course of terbinafine, the most common oral agent prescribed for onychomycosis, but this also had produced no difference in the appearance of the nail.

She had subsequently sought the care of a dermatologist. This physician had prescribed, despite the inordinate expense, one of the new topical agents for nail fungus. The patient managed to obtain the medicine and used it faithfully as prescribed. Much to her dismay, its effectiveness did not match the medications cost and no real transformation was forthcoming. Understandably, my patients frustration was mounting, which brought her in to see me.

Experts in fungal disease recognize the difficulties in treating the resistant, disfiguring nail changes associated with this type of infection. One of the most challenging aspects of these is the diagnosis: people assume they know the cause. Obviously, her physicians had made assumptions regarding the diagnosis. Yet studies reveal only about half the time is the discoloration, the thickening, and the changes in shape, due to a fungal infection. To accurately ascertain the cause of your nail transformations, a specimen for biopsy must be obtained, which is sent to a specialized lab. This sometimes requires the use of a local anesthetic, but is the best way to get a definitive diagnosis.

As you may not have guessed, the individual in question was not diagnosed with onychomycosis (fungal nails) but psoriatic nails. Psoriasis is a chronic disease causing inflammation of various tissues, especially skin, resulting in the rapid overgrowth of skin cells. It is not due to an allergy or a bad diet. For this reason, it is not treatable with dietary changes. Although there is a strong genetic component, environmental factors are of critical importance. About 1 to 2% of the global population has some form of psoriasis, with considerable differences among regions and people of varying skin types. Neither gender nor race predilection appears to exist. Approximately half of those with psoriasis will exhibit nail alterations at some point.

Nail psoriasis causes changes to your fingernails and/or toenails. These changes are mistaken for a fungal infection far too often. Inappropriate, since they are treated very differently. One is an infection (and can spread), while the other is an autoimmune condition. The occurrence of psoriatic nail changes is indicative of a poorer prognosis overall. Nail psoriasis also portends a higher risk of developing psoriatic arthritis. Some common signs of nail psoriasis include the appearance of tiny dents in the nail (pitting), discoloration (white, yellow or brown), and nail separation, the lifting of the nail off the digit. My patient had all these changes, the classic three characteristics of the psoriatic nail.

A wonderful diagnostic tool I used in this patients case was a dermatoscope. Basically, it is a small, hand-held, very portable microscope. It allows the physician to easily observe microscopic changes of the skin, even into the skin. The benefits are innumerable and especially beneficial in podiatric medicine. My latest iteration is digital and plugs into the laptop, magnifying minute changes for all to see. (It can be quite a show.) Still, the gold standard in dermatologic medicine is histologic testing. The science of analyzing pathologic tissues has come so far, allowing us to learn so much from so little material.

Like skin psoriasis, nail psoriasis is chronic but may improve or worsen for no discernible reason. Trauma has a critical role in exacerbations and remissions of nail psoriasis. For example, because artificial nails increase mechanical stress to the nail plate, they will reliably worsen nail psoriasis. Those engaged in professions demanding significant use of the fingers will often experience an increase in the severity and frequency of psoriatic attacks. The same applies to any more physical means of employment, such as a job requiring the frequent pulling or pushing of heavy objects.

In most cases, nail psoriasis follows the skin changes of psoriasis and is therefore easy to diagnose. But in approximately five percent of cases, nail psoriasis occurs without the skin lesions and can pose a real diagnostic challenge, as in the case of our protagonist. This is especially true when alterations in the nail are atypical such as a single nail being affected. The analysis of a specimen by a pathologist, termed histopathology, is usually all that is necessary to make the diagnosis, provided the biopsy specimen is appropriately obtained.

Genes are the most important factor in an individuals psoriatic manifestations. Many different genes contribute to psoriasis and how it develops in each sufferer, which partially explains the enormous variability in the response to treatment. Trauma is the most obvious causative agent other than genetic. Some of the identified risk factors for developing psoriasis include smoking, obesity, and alcohol use. Trauma to the nail unit will inevitably exacerbate the condition or induce recurrences.

The many treatments available give evidence that none is the ideal therapy. Nail psoriasis treatments require a long time, as the nail is a slow-growing skin structure. The effect of any nail treatment cant be accurately evaluated before a year has elapsed, at a minimum. This is how long, on average, it takes for a big toenail to grow out and this length of time must pass prior to determining maximal improvement of any therapy. Additionally, excluding the presence of a fungal infection is a necessity when starting nail psoriasis therapy (as our patient discovered).

Nail psoriasis is highly resistant to almost all topical treatments, and thus this approach is less commonly used. The problem with all topical drugs is their limited penetration to the diseased tissue. As with fungal nails, reducing the barrier in some fashion increases the benefits of a topical. This can be achieved through nail removal, thinning of the nail, or drilling of small holes in the nail to provide better access of the medicine. As is often the case in these matters, topicals are nearly always safer. Those systemic therapies used to produce clearing of the skin are usually effective also in nail psoriasis. These can also be injected around the nail root, which largely avoids the systemic side effects.

Nail psoriasis can have a tremendous impact on many aspects of life for those afflicted. Need I say, the changes are negative ones, as a rule. With such a common problem (one out of every fifty people), one might hope there would be some semblance of a cure, but there is not. Surprisingly, nail psoriasis is only briefly mentioned in most guidelines on the diagnosis and treatment of psoriasis.

Truly, modern medicine has come so far, yet there is much we simply do not know. Still, there are treatments for controlling the signs and symptoms of this disease. Early and accurate identification is the key to proper treatment. Any therapy works better when its used on the appropriate condition. Get your nail changes looked at (REALLY closely) by a specialist. And get a biopsy. It only makes sense!

Editors note: Dr. Conway McLean is a physician practicing foot and ankle medicine in the Upper Peninsula, with a move of his Marquette office to the downtown area. McLean has lectured internationally on wound care and surgery, being double board certified in surgery, and also in wound care. He has a sub-specialty in foot-ankle orthotics. Dr. McLean welcomes questions or comments

Today's breaking news and more in your inbox

See the original post here:
Health Matters: Mystery of the diseased toenail | News, Sports, Jobs - Marquette Mining Journal

Read the Rest...

In Depth Analysis and Survey of COVID-19 Pandemic Impact on Global Nanometals Market 2020 Key Players Reinste, Eprui Nanomaterials & Microspheres,…

§ July 5th, 2020 § Filed under Nanomaterials Comments Off on In Depth Analysis and Survey of COVID-19 Pandemic Impact on Global Nanometals Market 2020 Key Players Reinste, Eprui Nanomaterials & Microspheres,…

Report is a detailed study of the Nanometals market, which covers all the essential information required by a new market entrant as well as the existing players to gain a deeper understanding of the market.The primary objective of this research report named Nanometals market is to help making reliable strategic decisions regarding the opportunities in Nanometals market. It offers business accounts, industry investors, and industry segments with consequential insights enhancing decision making or call us on +1-312-376-8303.

Request Report from CMR Website:

Global and Regional Nanometals Market Segmentation by Type: Silver, Gold, Platinum, Other

Global Nanometals Market Segmentation by Applications: Electronics, Energy, Pharmaceutical Industry, Other

Major Market Players with an in-depth analysis: Reinste, Eprui Nanomaterials & Microspheres, Baikowski, ABC Nanotech, Amag Pharmaceuticals, Chengyin Technology, Nanoamor, Polyscience, Bangs Laboratories, Duke Scientific, SkySpring Nanomaterials, DA Nanomaterials, Diamond Fusion International, Silco International, Surrey Nanosystems, DuPont, NanoE

Request Free Sample Copy of Nanometals Market Research Report@

The Nanometals market report offers the current state of the market around the world. The report starts with the market outline and key components of the Nanometals market which assumes a significant job for clients to settle on the business choice. It additionally offers the key focuses to upgrade the development in the Nanometals market. Some fundamental ideas are likewise secured by reports, for example, item definition, its application, industry esteem chain structure and division which help the client to break down the market without any problem. Also, the report covers different factors, for example, arrangements, efficient and innovative which are affecting the Nanometals business and market elements.

Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample): Click Here> Download Sample Report of Nanometals Market Report 2020 (Coronavirus Impact Analysis on Nanometals Market)

The research comprises primary information about the products. Similarly, it includes supply-demand statistics, and segments that constrain the growth of an industry. It also includes raw materials used and manufacturing process of Nanometals market. Additionally, report provides market drivers and challenges & opportunities for overall market in the particular provincial sections.

Competitive Analysis has been done to understand overall market which will be helpful to take decisions. Major players involved in the manufacture of Nanometals product has been completely profiled along with their SWOT. Some of the key players include Reinste, Eprui Nanomaterials & Microspheres, Baikowski, ABC Nanotech, Amag Pharmaceuticals, Chengyin Technology, Nanoamor, Polyscience, Bangs Laboratories, Duke Scientific, SkySpring Nanomaterials, DA Nanomaterials, Diamond Fusion International, Silco International, Surrey Nanosystems, DuPont, NanoE. It helps in understanding their strategy and activities. Business strategy described for every company helps to get idea about the current trends of company. The industry intelligence study of the Nanometals market covers the estimation size of the market each in phrases of value (Mn/Bn USD) and volume (tons). Report involves detailed chapter on COVID 19 and its impact on this market. Additionally, it involves changing consumer behavior due to outbreak of COVID 19.

Further, report consists of Porters Five Forces and BCG matrix as well as product life cycle to help you in taking wise decisions. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Regional Analysis for Nanometals North America (United States, Canada) Europe (Germany, Spain, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, India, Australia, and South Korea) Latin America (Brazil, Mexico, etc.) The Middle East and Africa (GCC and South Africa)


Chapters Define in TOC (Table of Content) of the Report: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation Overview Chapter 2: COVID Impact Chapter 3: Market Competition by Manufacturers Chapter 4: Production by Regions Chapter 5: Consumption by Regions Chapter 6: Production, By Types, Revenue and Market share by Types Chapter 7: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 8: Complete profiling and analysis of Manufacturers Chapter 9: Manufacturing cost analysis, Raw materials analysis, Region-wise Manufacturing expenses Chapter 10: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 11: Marketing Strategy Analysis, Distributors/Traders Chapter 12: Market Effect Factors Analysis Chapter 13: Market Forecast Chapter 14: Nanometals Research Findings and Conclusion, Appendix, methodology and data source To check the complete Table of Content click here: @

The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market. The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2027.

About Us: Cognitive Market Research is one of the finest and most efficient Market Research and Consulting firm. The company strives to provide research studies which include syndicate research, customized research, round the clock assistance service, monthly subscription services, and consulting services to our clients.

Contact Us: +1-312-376-8303 Email: Web:

**********Download the Entire Report*************************************************


In Depth Analysis and Survey of COVID-19 Pandemic Impact on Global Nanometals Market 2020 Key Players Reinste, Eprui Nanomaterials & Microspheres,...

Read the Rest...

Research On Global Magnetite Nanoparticles Market (impact of COVID-19) with Top Players: Nanografi Nano Technology,US Research Nanomaterials and…

§ July 5th, 2020 § Filed under Nanomaterials Comments Off on Research On Global Magnetite Nanoparticles Market (impact of COVID-19) with Top Players: Nanografi Nano Technology,US Research Nanomaterials and…

Global Magnetite Nanoparticles Market: Trends Estimates High Demand by 2027

The Magnetite Nanoparticles Market 2020 report includes the market strategy, market orientation, expert opinion and knowledgeable information. The Magnetite Nanoparticles Industry Report is an in-depth study analyzing the current state of the Magnetite Nanoparticles Market. It provides a brief overview of the market focusing on definitions, classifications, product specifications, manufacturing processes, cost structures, market segmentation, end-use applications and industry chain analysis. The study on Magnetite Nanoparticles Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape.

It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Magnetite Nanoparticles market. All findings and data on the global Magnetite Nanoparticles market provided in the report are calculated, gathered, and verified using advanced and reliable primary and secondary research sources. The regional analysis offered in the report will help you to identify key opportunities of the global Magnetite Nanoparticles market available in different regions and countries.

The final report will add the analysis of the Impact of Covid-19 in this report Magnetite Nanoparticles industry.

Some of The Companies Competing in The Magnetite Nanoparticles Market are: Nanografi Nano Technology,US Research Nanomaterials,Nanoshell LLC,Strem Chemicals,American Elements,Cathay Industries,TodaKogyo,NN-Labs,NanoComposix,Nvigen,CAN-GmbH.

Get a Sample Copy of the [emailprotected]

The report scrutinizes different business approaches and frameworks that pave the way for success in businesses. The report used Porters five techniques for analyzing the Magnetite Nanoparticles Market; it also offers the examination of the global market. To make the report more potent and easy to understand, it consists of info graphics and diagrams. Furthermore, it has different policies and improvement plans which are presented in summary. It analyzes the technical barriers, other issues, and cost-effectiveness affecting the market.

Global Magnetite Nanoparticles Market Research Report 2020 carries in-depth case studies on the various countries which are involved in the Magnetite Nanoparticles market. The report is segmented according to usage wherever applicable and the report offers all this information for all major countries and associations. It offers an analysis of the technical barriers, other issues, and cost-effectiveness affecting the market. Important contents analyzed and discussed in the report include market size, operation situation, and current & future development trends of the market, market segments, business development, and consumption tendencies. Moreover, the report includes the list of major companies/competitors and their competition data that helps the user to determine their current position in the market and take corrective measures to maintain or increase their share holds.

What questions does the Magnetite Nanoparticles market report answer pertaining to the regional reach of the industry?

The report claims to split the regional scope of the Magnetite Nanoparticles market into North America, Europe, Asia-Pacific, South America & Middle East and Africa. Which among these regions has been touted to amass the largest market share over the anticipated duration

How do the sales figures look at present how does the sales scenario look for the future?

Considering the present scenario, how much revenue will each region attain by the end of the forecast period?

How much is the market share that each of these regions has accumulated presently

How much is the growth rate that each topography will depict over the predicted timeline

A short overview of the Magnetite Nanoparticles market scope:

Global market remuneration

Overall projected growth rate

Industry trends

Competitive scope

Product range

Application landscape

Supplier analysis

Marketing channel trends Now and later

Sales channel evaluation

Market Competition Trend

Market Concentration Rate

Reasons to Read this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments


Chapter 1:Magnetite Nanoparticles Market Overview

Chapter 2: Global Economic Impact on Industry

Chapter 3:Magnetite Nanoparticles Market Competition by Manufacturers

Chapter 4: Global Production, Revenue (Value) by Region

Chapter 5: Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6: Global Production, Revenue (Value), Price Trend by Type

Chapter 7: Global Market Analysis by Application

Chapter 8: Manufacturing Cost Analysis

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Magnetite Nanoparticles Market Effect Factors Analysis

Chapter 12: GlobalMagnetite Nanoparticles Market Forecast to 2027

Get Complete Report @

About Us:

Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

Ph: +1-352-353-0818 (US)

Original post:

Research On Global Magnetite Nanoparticles Market (impact of COVID-19) with Top Players: Nanografi Nano Technology,US Research Nanomaterials and...

Read the Rest...

How a Chinese firm with Canadian ties jumped to the front of the coronavirus vaccine race – Financial Post

§ July 5th, 2020 § Filed under Genetically Modified Humans Comments Off on How a Chinese firm with Canadian ties jumped to the front of the coronavirus vaccine race – Financial Post

When a group of Chinese scientists gathered over barbecue and beer in a Toronto backyard a decade ago, talk drifted to their homelands vaccines, which had long lagged the developed world on quality and safety. Four of them decided to act.

They left top positions at global pharmaceutical companies in Canada to set up a biotechnology firm half a world away in Tianjin, China, hoping to produce vaccines on par with Western countries. Now, that company, CanSino Biologics Inc., is vaulting into the global spotlight as connections on both sides of the Pacific make it one of the front-runners in the race for a coronavirus vaccine.

CanSinos Chinese-born chief executive officer, Yu Xuefeng, formerly a senior executive at drugmaker Sanofis Canadian vaccine operations, has maintained relationships in Canada and China even as geopolitical disagreements polarize both countries. Yu has boosted his firms scientific prowess by tying up with the Canadian governments largest research organization. At home, hes worked with a prominent Chinese military scientist, first on an Ebola vaccine and now on CanSinos experimental coronavirus shot.

In May, CanSino became the first globally to publish a full scientific study on its early human trials, an important step because it allows researchers worldwide to assess a vaccines potential.

The company which is yet to generate revenue and logged a US$22 million loss last year has so far kept up with, and occasionally even outpaced, Western pharmaceutical giants with the speed of its initial coronavirus vaccine trials. The research is still too nascent to know if the shot from CanSino, or indeed any company, will provide the magic bullet countries are seeking to open up while the pandemic rages. But CanSinos inroads show Chinas young biotechnology industry is becoming a global contender, and a powerful tool for President Xi Jinping.

CanSino deserves credit for the speed with which they pushed the vaccine through pre-clinical studies and human testing, said Wang Ruizhe, a pharmaceutical industry analyst at Capital Securities Corp. in Shanghai. It tells you something about their ability to mobilize and leverage the resources that it takes to get all these done. The resources required here are substantial.

A spokesperson for the Chinese company, citing media reports in May, said Canadian Prime Minister Justin Trudeau is supportive of the Canadian researchers working on clinical trials for a coronavirus vaccine with CanSino.

Chinas pharmaceutical industry has been dogged by safety incidents and quality scandals. But in recent years, parts of it have grown more advanced as hundreds of Chinese scientists trained in the West have come home.

Called hai gui, or sea turtles, these returnees have capitalized on relationships and expertise gained in countries like the U.S. and Canada, and created new companies. CanSinos CEO Yu 57, who has a doctorate from Canadas McGill University in microbiology and was the head of vaccine development and production at Sanofi Pasteur in Canada belongs to this new breed of executives.

In the prospectus for CanSinos 2019 public offering in Hong Kong, Yu described the difficult choices he and his colleagues made in forging their new path back home in China.

Most of our families stayed in Canada, and we could only see them a few times a year, he wrote. When you think about your young kids and teenagers growing up without dads, when you know your wife had to shovel out of 10 inches of deep snow early morning in -20C wind chill all by herself those were the tough moments.

The name CanSino represents the Chinese characters for health, hope and promises, while in English its a combination of Canada and China. Besides Yu, other top officials at the firm have Canadian connections. Chief Scientific Officer Zhu Tao was also a senior scientist at Sanofi Pasteur in Canada. The companys success has relied on threading the needle between both nations.

In February 2014, about five years after returning to China, Yu licensed a technology from the National Research Council of Canada called HEK 293 cell lines, which is required to produce large quantities of a vaccine reliably. That science went on to partly underpin CanSinos viral vector technology.

An advanced way to make a vaccine, a viral vector is a genetically modified virus that is no longer harmful to humans, but can serve as a vehicle to carry the genes of another germ to prepare the immune system for attack. Few Chinese companies had that technology in 2014, when a Chinese army researcher called Chen Wei began looking for viral vector expertise to produce a vaccine amid Africas Ebola outbreak.

A major general in Chinas Peoples Liberation Army, Chen headed the Institute of Biotechnology at the countrys Academy of Military Medical Sciences. She went on to work with CanSino to develop an Ebola vaccine that in 2017 was approved in China for emergency use and national stockpiling.

Chen has star status in China. In a nationalistic movie called Wolf Warrior II, the character of a scientist who develops a vaccine against a deadly African virus is believed to be modelled on her. She developed a therapy used by Chinese health workers during the SARS outbreak of 2003.

Chen is also known for a singular dedication to her work. In a 2004 interview with state-run CCTV, she said she presented her findings on the SARS therapy to Beijings municipal authorities after dosing her four-year-old son with it for two months because she was so sure about her research.

CanSinos long-running relationship with Chen paid off again this year. CanSino and her team raced through pre-clinical studies on the coronavirus vaccine called Ad5-nCoV. They secured Beijings help on everything from isolating virus strains to animal testing. Chen and the institute couldnt be reached for comment.

The team started human clinical trials in Wuhan, the Chinese city where the coronavirus first emerged, on March 16. Massachusetts-based Moderna Inc., seen as one of the best contenders to produce an American vaccine, started its tests in the U.S. the same day. Less than a month later, CanSino began the second phase of wide-scale human trials. On May 22, when it published a study in the medical journal the Lancet, the results were mixed: The shot appeared to be safe and generated some immune response, but there were shortcomings.

Viral vector technology can have limitations when some people already have pre-existing immunity to the vector virus used to create the vaccine. This was the case for the adenovirus a genetically-altered cold-causing virus which CanSino used for its vaccine. Many of those with pre-existing adenovirus immunity showed diminished response to its coronavirus shot in the Lancet study.

For upcoming trials in Canada, CanSino has added a booster shot for some participants to attempt to address the lacklustre response from those with pre-existing immunity to the adenovirus vector, according to a person with knowledge of its trial design who didnt want to be named discussing information thats not public.

CanSino is in the game and its about where the other so-called leaders are, said William Haseltine, a former Harvard University HIV researcher. Whether anybody will cross the finish line where we ever can see safety data that we would like to see is unknown.

CanSino is in the game and it's about where the other so-called leaders are

Final-stage trials could yet stymie CanSinos outsized ambitions. Its Ebola vaccine was approved on an emergency basis after two stages of human testing, but the company never completed the final phase as the epidemic petered out in Africa. CanSino doesnt generate much revenue because most of its products, including two late-stage meningitis vaccines, are still in development.

The company has received some funding from Beijing for the coronavirus vaccine, although the amount isnt large, the person familiar with its trials said.

CanSinos founders ties with Canada are once again proving fortuitous as it looks to conduct Phase III tests on its vaccine. Still, there could be challenges in conducting the sizable studies required in the final stages if new coronavirus infections continue to taper in Canada. China has largely stamped out its outbreak.

Researchers at Dalhousie Universitys Canadian Center for Vaccinology, who are leading the clinical trials, have said they hope to start Phase III studies of the CanSino shot as early as this fall. Canadas National Research Council said if the vaccine candidate is approved by authorities there, it has the option to produce doses of the vaccine for emergency pandemic use in Canada. (CanSino is responsible for funding its own trials, Health Canada, the governments health agency, said in an email.)

Meanwhile, Chinas reputation in Canada already damaged by Beijings reaction to the arrest of Huawei Technologies Co.s chief financial officer in Vancouver has been dealt a further blow by the pandemic and perceptions China hid the virus initially. That could fuel more scrutiny of CanSino and its vaccine in Canada.

Other companies are also racing ahead. Moderna is set to test its vaccine among 30,000 people in the U.S. in July, while an early-stage trial of a Pfizer Inc. and BioNtech SE shot showed its safe and prompted patients to produce antibodies against the coronavirus. A vaccine co-developed by the University of Oxford and AstraZeneca Plc also started the final stage of human testing in Brazil in June.

At home, state-run vaccine developer China National Biotec Group Co. has secured approval from health authorities in the U.A.E. to conduct Phase III testing for the two shots it developed against the coronavirus. Beijing-based Sinovac Biotech Ltd. has inked a deal to do final tests in Brazil, too. The outcome for all of these companies and CanSino will only be known once this ultimate stage of scientific studies is complete.

The viral vector CanSino is using is a relatively safe approach compared to other techniques but its hard to make a call on efficacy for now, said Wang, the Shanghai-based analyst. Theres no shortage of histories where promising efforts made it to the last stage of testing only to see things fall apart.

Read the original here:

How a Chinese firm with Canadian ties jumped to the front of the coronavirus vaccine race - Financial Post

Read the Rest...

New swine flu with pandemic potential identified by China researchers – The Guardian

§ July 5th, 2020 § Filed under Genetically Modified Humans Comments Off on New swine flu with pandemic potential identified by China researchers – The Guardian

Warning comes after researchers took 30,000 nasal swabs from pigs between 2011 and 2018. Photograph: Alamy Stock Photo

Researchers in China have discovered a new type of swine flu that is capable of triggering a pandemic, according to a study in the US science journal PNAS, although experts said there is no imminent threat.

Named G4, it is genetically descended from the H1N1 strain that caused a pandemic in 2009.

It possesses all the essential hallmarks of being highly adapted to infect humans, said the authors, scientists at Chinese universities and Chinas Center for Disease Control and Prevention, in the study published on Monday.

Between 2011 and 2018, researchers took 30,000 nasal swabs from pigs in slaughterhouses in 10 Chinese provinces and in a veterinary hospital, allowing them to isolate 179 swine flu viruses.

The majority were of a new kind that has been dominant among pigs since 2016.

The researchers then carried out various experiments including on ferrets, which are widely used in flu studies because they experience similar symptoms to humans.

G4 was observed to be highly infectious, replicating in human cells and causing more serious symptoms in ferrets than other viruses do.

Tests also showed that any immunity humans gain from exposure to seasonal flu does not provide protection from G4.

More than one in 10 swine workers in the new study had already been infected, according to antibody blood tests which showed exposure to the virus.

The tests also showed that as many as 4.4% of the general population also appeared to have been exposed.

The virus has therefore already passed from animals to humans but there is no evidence yet that it can be passed from human to human the scientists main worry.

The World Health Organization (WHO) will read the Chinese study carefully, spokesman Christian Lindmeier told a Geneva briefing on Tuesday, saying it was important to collaborate on findings and keep tabs on animal populations.

It also highlights we cannot let our guard down on influenza and need to be vigilant and continue surveillance even in the coronavirus pandemic, he added.

Chinese Foreign Ministry spokesman Zhao Lijian told a daily news conference on Tuesday that China was closely following developments. We will take all necessary measures to prevent the spread and outbreak of any virus, he said.

The study highlights the risks of viruses crossing the species barrier into humans, especially in densely populated regions in China, where millions live close to farms, breeding facilities, slaughterhouses and wet markets.

The current coronavirus sweeping the world is believed to have originated in horseshoe bats in southwest China and could have spread to humans via a seafood market in the central city of Wuhan, where the virus was first identified.

It is of concern that human infection of G4 virus will further human adaptation and increase the risk of a human pandemic, the researchers wrote.

The authors called for urgent measures to monitor people working with pigs.

James Wood, head of the department of veterinary medicine at Cambridge University, said: The work comes as a salutary reminder that we are constantly at risk of new emergence of zoonotic pathogens and that farmed animals with which humans have greater contact than with wildlife may act as the source for important pandemic viruses.

A zoonotic infection is caused by a pathogen that has jumped from a non-human animal into a human.

Although it is capable of infecting humans, there is no imminent risk of a new pandemic, said Carl Bergstrom, a biologist at the University of Washington. Theres no evidence that G4 is circulating in humans, despite five years of extensive exposure, he said on Twitter. Thats the key context to keep in mind.

Read the original here:

New swine flu with pandemic potential identified by China researchers - The Guardian

Read the Rest...

28 cool health things that started with a Canadian – Regina Leader-Post

§ July 5th, 2020 § Filed under Nano Medicine Comments Off on 28 cool health things that started with a Canadian – Regina Leader-Post

Alzheimers in mice

Dr. Peter St George-Hyslopof the Weston Brain Institute identified a number of genes responsible for Alzheimers disease and nerve cell degeneration using mouse models. He has published nearly 400 papers on Alzheimers research.

In the early 2000s, he essentially cured Alzheimers in mice through the discovery that certain types of sugars would block the development of amyloid proteins, one of the hallmarks of Alzheimers.


University of Torontos Brenda Andrews pioneered the field of functional genomics and systems biology to discover how genes and their protein products regulate cell function in health and disease. She is also an elected member of the National Academy of Sciences and a specialist in the application of artificial intelligence to personalized medicine.

Kathleen Dickson is a former chief technician from the Montreal Neurological Institute.

John Bergeron is the Emeritus Robert Reford Professor and a Professor of Medicine at McGill University.

Dont miss the latest on COVID-19, reopening and life. Subscribe to Healthings daily newsletterComing Out of COVID.

The rest is here:
28 cool health things that started with a Canadian - Regina Leader-Post

Read the Rest...

The permafrost pandemic: could the melting Arctic release a deadly disease? – Unearthed

§ July 5th, 2020 § Filed under Nano Medicine Comments Off on The permafrost pandemic: could the melting Arctic release a deadly disease? – Unearthed

Dr Brigitta Evengrd, who led in putting together the historic Hannover event, was far less ready to dismiss the threat of frozen bacteria she sees the emerging antibiotic resistance crisis as a threat multiplier.

After returning from a brief hiatus practicing medicine as Swedens doctors were called in to support Covid-19 efforts, she told Unearthed: My worst case scenario? Whats happening already every now and then, there was an outbreak in Madagascar just a few years back. And thats antibiotic resistant Pasteurella pestis plague.

Though she admitted the risk of antibiotic-resistant diseases emerging is thin, it is not impossible.

The antibiotic resistance pandemic will kill annually more than the coronavirus pandemic.

As for possible pandemics from the Arctic? The two that we know could come out of the permafrost are anthrax and thats pox viruses, other than that its pandoras box.

Finding a host

Once unfrozen, these permafrost microbes must find a host in order to survive. But they have a problem: there arent many people who live in the area, and those that do often indigenous villages are not in frequent contact with outsiders, meaning the spread of infection would likely be limited.

The real danger is not the thawing of permafrost per se, Dr Claverie said, its that humans the Russians mainly are now starting to exploit the Arctic regions, and are making big holes by which to excavate layers permafrost that are up to a million years old.

This is the recipe for disaster because you have humans here and you have the virus when it is fresh. When viruses are released from the permafrost in nature, what happens? They fall into the river. They are exposed to oxygen, which is bad for viruses. They are exposed to light, which is also bad for viruses. And so they will not be revived for very long if they dont find a host very quickly.

So its like the permafrost is the ocean, and the microbes the sharks. Dont go surfing when there are sharks in the water and things should be alright.

Dr Abergel said: If [the viruses] come into contact with a proper host then they will reactivate. So if you put a human in a place with frozen viruses associated with pandemic then those humans could be infected and replicate the virus and start a new pandemic.

But as Dr Evengrd pointed out, humans are not the only potential hosts out there.

With climate change, we have movement of animals. People, we tend to stay in our homes if we are well enough. If you are near the coastline of Bangladesh, lets say, you may already be moving inland. The biggest migration of climate refugees is still inside their home countries. But animals, they move.

She stressed that climate change has sent the global ecosystem into flux, and its nigh impossible to say where things will end up.

Moose and hares, for instance, are migrating north as vegetation crops up, and then of course theres birds and fish and their sometimes globe-spanning migratory patterns.

These animals can bring microorganisms into virgin areas, Dr Evengrd said, and things will happen that we simply cant predict. You can say the Arctic is spacious and not so populated but there are people coming and going yes, miners and there are microorganisms coming in there with animals and even coming up from the earth. The dynamic that is ongoing is new.

The Coronavirus experience, she said, has just reinforced my belief that what Im doing is absolutely important.

Im not surprised, its not a question of if this was going to happen it was when. The only enemy we really have is our own ignorance that were not preparing for this. We have all this knowledge, its really not that new. This dynamic process that were getting into with the climate change era. We should be better prepared, instead were sitting here paralysed by fear.

This is a warning from nature and its going to happen again and again and again, Im sure.

More here:
The permafrost pandemic: could the melting Arctic release a deadly disease? - Unearthed

Read the Rest...

Leveraging The Power Of Full Spectrum Hemp Oil (Synchronicity) – Anti Aging News

§ July 5th, 2020 § Filed under Nano Medicine Comments Off on Leveraging The Power Of Full Spectrum Hemp Oil (Synchronicity) – Anti Aging News

1004 0 Posted on Jul 01, 2020, 6 p.m.

Article courtesy of: Dr. Joel Kahn, MD, who is a Clinical Professor of Medicine at Wayne State University School of Medicine, one of the world's top cardiologists, best selling author, lecturer, and a leading expert in plant-based nutrition and holistic care.

Did you attend biology classes in school? If so, you may remember your first introduction to the cardiovascular system, how the rhythmic beating of the heart circulates oxygen and nutrients throughout the body. Most likely, that first lesson was relatively simple to understand.

Eventually, the lessons got more complicated. You soon learned that dietary choices, physical habits, and sleep quality all play a significant role in cardiovascular health. Once you understood that heart health is also affected by inflammation, free radical damage, and hormone levels, you recognized the importance of maintaining a balance between essential bodily processes.

A relatively short time ago, researchers identified a regulatory system that influences nearly every essential function in the body, including processes directly impacting cardiovascular health. They also discovered that this universal regulatory system responds to the phytocannabinoids, terpenes, and flavonoids in hemp. Of the more than 100 cannabinoids in Full-Spectrum Hemp Oil, its the therapeutic potential of CBD(cannabidiol) that has people talking. CBD is a phytocannabinoid with anxiolytic, analgesic, anti-inflammatory, and anti-spasmodic properties (1).

If youre intrigued by the therapeutic potential of Hemp Oil, its important to understand that the composition of the oil you select will have a considerable impact on your health. For the best experience, youll need to know how your body will react to hemp. Youll also need to know the differences between CBD oil and Whole-Plant Full-Spectrum Hemp Oil.

Investigating the Health and Wellness Potential of Phytocannabinoids

If youve been investigating the therapeutic potential of phytocannabinoids, you may already have a basic understanding of how these plant elements relay urgent messages to the receptors of the endocannabinoid system (ECS)(2), the largest regulatory system in the body. What you may not realize is how essential this communication is to your overall health and wellbeing.

Modern researchers believe the main purpose of ECS signaling is to regulate the processes involved in homeostasis (the internal balance all living organisms must maintain to survive). When internal or external forces threaten that balance, homeostatic processes restore equilibrium (3).

That equilibrium affects nearly every essential function in your body. The ECS messengers (endocannabinoids) are produced by your body as needed and then broken down by metabolic enzymes once their messages are delivered to cannabinoid receptors. The response initiated by the receptors depends on the chemical composition of the message received. Just a few of the numerous processes regulated by ECS signaling (4) include:

Ideally, your body would make all the ECS messengers needed to ensure that all internal processes run efficiently. But, this is an ideal scenario. Under the influences of stress, illness, or injury, the demand for endocannabinoids can exceed the available supply.

When demand exceeds supply, essential communication between endocannabinoids and cannabinoid receptors becomes less efficient. Important messages may not be received. Since phytocannabinoids mimic the effects of the endocannabinoids produced in your body, supporting ECS function with Hemp Oil can potentially restore essential balance.

How Supporting ECS Function Can Protect Cardiovascular Health

Today, many cannabinoid researchers believe endocannabinoid deficiencies cause disease. Current research appears to support the connection between the lack of ECS messengers and fibromyalgia, IBS, migraine, several neurodegenerative disorders, and other treatment-resistant syndromes (5).

The evidence supporting the therapeutic potential of phytocannabinoids for a number of health concerns is based on animal studies, laboratory tests, clinical trials, and user reviews. In particular, the studies investigating the cardiovascular benefits of CBD and other phytocannabinoids are particularly intriguing.

Preliminary research suggests the phytocannabinoids in Hemp Oil may be beneficial in reducing the risk of heart disease for people with diabetes (6). The research also shows that cannabidiol may protect the heart from ischemic damage. In animal studies, the CBD in Hemp Oil shows potential for stabilizing cardiac arrhythmia, a condition that causes the heart to beat too fast or in an irregular pattern (7)

Of course, far more testing needs to be done before reaching a universal consensus on hemp. Thats why Its important to note that CBD and other phytocannabinoids in Hemp Oil are not intended to be used as a preventative, treatment, or cure for any known health conditions. However, animal studies, lab results, and user testimonials suggest Hemp Oil products may be beneficial for heart health. To help determine how Hemp Oil can help you, consider the value of the following observations.

Phytocannabinoids May Help You Get the Rest You Need

While occasional sleeplessness is unlikely to cause irreparable damage, chronic sleep deprivation can take a considerable toll on your overall health. Current research shows that adults who sleep less than seven hours each night have an increased risk of Type 2 diabetes, weight gain, high blood pressure, and other chronic health conditions that can contribute to a higher risk of heart disease (8) Numerous Hemp Oil users claim nightly use improves sleep quality. Thats not entirely surprising. Sleep and sleep cycles are regulated by the endocannabinoid system. The CBD in Hemp Oil is shown to stabilize sleep cycles and improve REM sleep. Plus, the anxiolytic and analgesic properties of cannabidiol have the potential to provide mood and nervous system support (9).

Hemp Oil May Help Your Body Manage the Impact of Stress

Stress initiates a cascade of events that can compromise your health. In response to physical or emotional stress, your body increases the production of adrenaline and the stress hormone cortisol. The longer the duration of the stress-inducing experience, the longer it takes for your body to restore balance. Prolonged stress can result in chronic inflammation, high blood pressure, stroke, and heart attack. For women, the risk increases after menopause due to estrogen loss (10).

Unresolved stresses can also trigger insomnia and anxiety. Researchers have found that CBD and other minor cannabinoids in Hemp Oil interact with receptors directly involved in stress responses. These receptors include endocannabinoid, GABA, dopamine, and serotonin receptors (11). That interaction explains the anxiolytic properties of CBD and other plant-based cannabinoids. Essentially, plant cannabinoids may be critical in providing nervous system, balanced mood, and neuroprotective support.

Phytocannabinoids May Reduce Your Risk of Developing High Blood Pressure

When doctors measure blood pressure, they are evaluating the amount of force exerted on arterial walls as blood flows through them. When this force remains unnaturally high for long periods of time, it can cause considerable damage to blood vessels. This can result in a long list of potential complications, including atherosclerosis, chronic kidney disease, angina, and heart attack. Most people with high blood pressure never experience symptoms until problems develop (12).

Pre-clinical studies suggest that the CBD in Hemp Oil helps reduce blood pressure by initiating blood vessel dilation. Once blood vessels expand, there is less stress exerted on the arterial walls. A 2017 randomized study revealed that a single dose of CBD reduced the resting blood pressure and the stress-induced blood pressure increases of nine healthy volunteers (13). While the results of initial investigations are intriguing, further study is needed.

Hemp Oil Has the Potential to Calm Systemic Inflammation

Inflammation is a defense mechanism, a healing response initiated by your immune system. The reaction is a sign that an army of white blood cells is responding to an injury or fighting an infection. However, the same immune system response that protects your body from harm can also cause significant damage. Modern researchers believe chronic inflammation contributes to diabetes, arthritis, various cancers, and heart disease (14).

While several medications can alleviate inflammation caused by medical disorders, there are currently no pharmacological treatments for the low-level inflammatory responses triggered by sugar, trans fats, stress, and free radical damage. Research shows that CBD and several lesser-known phytocannabinoids have the potential to neutralize inflammation by inhibiting COX enzymes(15), delaying the breakdown of anandamide (16), and activating vanilloid receptors. The latter, vanilloid receptors, influence pain perception and temperature regulation.

Phytocannabinoids May Enhance Post-Workout Recovery

Regular exercise helps modify the risk factors for developing heart disease. As strength and endurance build, decreased strain on the heart is promoted by reduced blood pressure, improved fat to muscle ratios, and reduced inflammation. But, while exercise benefits your heart, it can take a significant toll on the rest of your body. The resultant sore muscles, joint stiffness, and temporary loss of muscle strength can derail even the strongest wills. Most post-workout pain is caused by microscopic tears to over-worked muscles (17).

The analgesic, anti-inflammatory, and anti-spasmodic properties of the many phytocannabinoids in Hemp Oil show considerable therapeutic potential for enhancing post-workout recovery. Using Hemp Oil before or after a strenuous workout may help your body recover faster, so the pain and discomfort of increasing the intensity of your workouts wont keep you on the sidelines.

The Significant Differences Between the Three Main Types of CBD Oil

CBD (cannabidiol) is the most abundant of the many phytocannabinoids found in Hemp Oil. When a manufacturer puts CBD Oil on a product label, that description tells you far less than you may realize. Not all CBD products contain the full spectrum of phytocannabinoids, terpenes, and other plant-based nutrients found naturally in the original plant source.

Up to 99% of the time, over-the-counter CBD Oil is made with a single cannabinoid blended with a carrier oil or is derived from plant oils that have been compromised by harsh extraction methods. Thats why its important to have a clear understanding of your options and realistic expectations about commercial CBD Oil preparations. To ensure you are selecting the best Hemp Oil for your needs, consider what you may achieve using the following products.

Understanding the Limitations of CBD Isolate

Isolating CBD from the numerous plant elements found in industrial hemp can greatly reduce its supportive potential. To produce CBD isolate, the cannabinoid-rich oil must first be separated from the plant matter. Most often, the production process begins with soaking the stalks, stems, and flowers of the plant in ethyl alcohol, a commonly used food additive. Hemp seeds dont contain CBD or other phytocannabinoids. The concern with this extraction method is the presence of potentially harmful residues after the alcohol evaporates from the Hemp Oil.

After the extraction process is complete, the oil is heated for a certain amount of time. Any extreme temperatures can compromise product potency. Next, a third step called winterization is used to remove the plants fatty acids, terpenes, additional cannabinoids, and other plant components. All thats left behind is a white, crystalline CBD powder lacking many of the nutrients found in the original plant source (18).

Navigating the Specifications of Broad-Spectrum CBD Oil

Hemp-derived products are labeled as broad-spectrum when they contain many of the phytocannabinoids, terpenes, and phytonutrients of the original plant. Although a considerable number of the minor cannabinoids are left intact, the trace amounts of THC (tetrahydrocannabinol) are removed through a process called chromatography (19). While hemp plants dont synthesize enough of this somewhat controversial cannabinoid to cause intoxication, CBD users who would rather avoid THC typically select Hemp Oil products made with CBD isolate or Broad-Spectrum Hemp Oil.

Broad-spectrum Hemp Oil contains CBD and a wide array of phytonutrients but doesnt contain the entire spectrum of nutrients from the original plant source. In some cases, individual cannabinoids are isolated and then recombined in different ratios.

Recognizing the Benefit Maximizing Effects of Full-Spectrum Hemp Oil Full-Spectrum Hemp Oil products are most often preferred by CBD enthusiasts looking to get the most benefit from their investment. Less processed than Broad-Spectrum Hemp Oil, Full-Spectrum Hemp Oil contains CBD plus the entire range of potentially beneficial phytocannabinoids, terpenes, flavonoids, and other plant components found in nature. Youll likely find that a significant number of companies favor CO2 extraction over other methods because the resulting product is cleaner than oils derived from soaking plant matter in alcohol.

Full-Spectrum Hemp Oil is believed to be the more potent of the three options because of a little-known phenomenon known as the Entourage Effect that maximizes the oils therapeutic potential. This theory is used to explain how the combined effects of the many cannabinoids, plant terpenes, and other plant elements work together synergistically, with each plant component enhancing the impact of the others. The combined effects of each phytonutrient are far greater than those accorded by individual plant elements (20).

How a LipidTrans Infusion Process Delivers a True Entourage Effect

Although many Hemp Oil companies claim their full-spectrum products contain all the phytocannabinoids, terpenes, and plant nutrients in the same ratios found in natural hemp plants, those claims may not be entirely accurate. To experience the full potential of a True Entourage Effect, your body needs access to the full range of polyphenols, essential fats, and phytocannabinoids commonly altered or removed during conventional production methods. Thus, in order to gain the most benefit from your investment, its important to select Hemp Oil products crafted without high pressure, extreme heat, or chemical solvents.

Functional Remedies Synchronicity Full-Spectrum, Whole-Plant Hemp Oil relies on the power of nature to deliver the highest quality Hemp Oil possible, LipidTrans Infusion. The lipid infusion process transfers all the plant nutrients, phytocannabinoids, and other beneficial compounds to a heart-healthy oil (MCT oil). This gentle process preserves the integrity of Hemp Oil, protecting the delicate balance found in nature. While Synchronicity Full-Spectrum Whole Plant Hemp Oil shows considerable potential for protecting heart health, the only way to know if its right for you is to try it. Ask Your Body. To ensure purity and potency, all Synchronicity Full-Spectrum, Whole-Plant Hemp Oil tinctures, capsules, and topical products are third-party tested and produced in a cGMP certified facility. cGMP certification guarantees all production processes meet or exceed FDA enforced manufacturing standards.

Originally posted here:
Leveraging The Power Of Full Spectrum Hemp Oil (Synchronicity) - Anti Aging News

Read the Rest...

Magnesium Derivatives size and Key Trends in terms of volume and value 2019-2022 – Apsters News

§ July 5th, 2020 § Filed under Nano Medicine Comments Off on Magnesium Derivatives size and Key Trends in terms of volume and value 2019-2022 – Apsters News

The Magnesium Derivatives Market research report added by Market Study Report, LLC, provides a succinct analysis on the recent market trends. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in the industry, in tandem with the growth strategies adopted by leading industry players.

The Magnesium Derivatives market study is a well-researched report encompassing a detailed analysis of this industry with respect to certain parameters such as the product capacity as well as the overall market remuneration. The report enumerates details about production and consumption patterns in the business as well, in addition to the current scenario of the Magnesium Derivatives market and the trends that will prevail in this industry.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @

What pointers are covered in the Magnesium Derivatives market research study?

The Magnesium Derivatives market report Elucidated with regards to the regional landscape of the industry:

The geographical reach of the Magnesium Derivatives market has been meticulously segmented into United States, China, Europe, Japan, Southeast Asia & India, according to the report.

The research enumerates the consumption market share of every region in minute detail, in conjunction with the production market share and revenue.

Also, the report is inclusive of the growth rate that each region is projected to register over the estimated period.

The Magnesium Derivatives market report Elucidated with regards to the competitive landscape of the industry:

The competitive expanse of this business has been flawlessly categorized into companies such as

Market Segment Analysis The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type Magnesia Magnesium Sulfate Magnesium Hydroxide Other

Segment by Application Water Treatment Medicine Cosmetics Animal Feed Other

Global Magnesium Derivatives Market: Regional Analysis The report offers in-depth assessment of the growth and other aspects of the Magnesium Derivatives market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region. Global Magnesium Derivatives Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019. The major players in the market include Causmag International, GRECIAN MAGNESITE, IBAR Nordeste, Martin Marietta Magnesia Specialties, Sinwon Chemical, Baymag, YINGKOU MAGNESITE CHEMICAL IND GROUP, Oksihim, Tateho, Gongyi Qianghong Magnesium Technology, Compass Minerals, Karnalyte Resources, Intrepid Potash, OLE Chemical, K+S Group, NIKOMAG, RHI Magnesita, etc.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]

Exclusive details pertaining to the contribution that every firm has made to the industry have been outlined in the study. Not to mention, a brief gist of the company description has been provided as well.

Substantial information subject to the production patterns of each firm and the area that is catered to, has been elucidated.

The valuation that each company holds, in tandem with the description as well as substantial specifications of the manufactured products have been enumerated in the study as well.

The Magnesium Derivatives market research study conscientiously mentions a separate section that enumerates details with regards to major parameters like the price fads of key raw material and industrial chain analysis, not to mention, details about the suppliers of the raw material. That said, it is pivotal to mention that the Magnesium Derivatives market report also expounds an analysis of the industry distribution chain, further advancing on aspects such as important distributors and the customer pool.

The Magnesium Derivatives market report enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.

You can Buy This Report from Here @

Some of the Major Highlights of TOC covers:

See more here:
Magnesium Derivatives size and Key Trends in terms of volume and value 2019-2022 - Apsters News

Read the Rest...

Gov. Walz is urged to require Minnesotans to wear masks in COVID-19 fight – msnNOW

§ July 5th, 2020 § Filed under Nano Medicine Comments Off on Gov. Walz is urged to require Minnesotans to wear masks in COVID-19 fight – msnNOW

Star Tribune/Star Tribune/Alex Kormann/Star Tribune/TNS Duluth Human Rights Officer Carl Crawford greeted Minnesota Gov. Tim Walz with an elbow bump last month.

Minnesota Gov. Tim Walz is being urged to require residents of the state to wear masks when out in public, as COVID-19 cases hit record highs nationally and health officials worry infections may regain dangerous momentum here.

Governors in states with rising COVID-19 numbers, including California, Kansas and Pennsylvania, have mandated mask use statewide in recent weeks, saying its a simple and effective step to slow the spread of a virus that has killed more than 127,000 Americans, including 1,445 in Minnesota. Even President Donald Trump, who has resisted wearing a mask in public, said Wednesday hes all for wearing masks, adding that people should wear them if they feel good about it.

Walzs potential step comes amid growing evidence for how masks can work in concert with other safety protocols health officials are pleading with people to adopt if masks are worn properly and made with the right materials. Physician groups in Minnesota and the state Health Department are now fully backing a mandate.

Thats been a vigorous conversation within the executive branch, and with the governor directly. And I think he is listening, Minnesota Health Commissioner Jan Malcolm said Wednesday.

It is our advice from the health departments perspective that this is so important and so effective and the evidence has gotten more and more clear on this point. We do recommend that it become a requirement at the statewide level.

When properly worn, cloth masks, like those made at home or bought from retail stores, are intended to capture the microscopic droplets of moisture on the wearers breath that are a main source for spreading the virus. Since people can be contagious without having symptoms of COVID-19, many health officials say its important they be worn all the time while in public. The mask must cover the nose and mouth to work to be most effective.

To date, more than a dozen states are requiring people to wear masks while in public.

Walz said Wednesday that hes considering factors, such as the continued spread of COVID-19 in Minnesota, as part of a daily evaluation of whether to issue an order requiring public mask-wearing statewide.

Does our thinking change as we start to see these numbers in other states? Yes, absolutely, Walz said Wednesday. But were still looking at our own.

The number of new lab-confirmed cases of COVID-19 nationally hit a new daily record of 48,365 on Tuesday, just ahead of the Independence Day holiday weekend.

Minnesota reported 426 newly confirmed cases of COVID-19 on Wednesday, bringing the statewide total of lab-confirmed cases to 36,716. Minnesotas rate of new positive cases declined during the first half of June on a seven-day average basis, but started climbing again June 16. The seven-day average surpassed 400 on June 26.

Yet the number of new deaths and hospitalizations from COVID-19 remain on downward trajectories in Minnesota. The state added four deaths of elderly, group-home residents to its tally of 1,445 COVID-19 fatalities on Wednesday.

Pressure for mandate

Walz, at the urging of physician groups and public health officials, is facing mounting pressure to declare a statewide mask order. Even some members of the states business community are watching closely.

Business leaders, who have been urging Walz to safely lift pandemic restrictions first declared in March, see both risks and benefits in such an order. The key is its scope, and whether it provides enough flexibility for businesses, said Doug Loon, president of the Minnesota Chamber of Commerce.

Safety and engaging workers and customers is the biggest priority for businesses right now because without safety and without reassuring customers, we will not have our economy back, Loon said. Theres plenty of evidence to show that face masks work.

In April, the federal Centers for Disease Control and Prevention (CDC) recommended that people wear cloth face coverings in places like grocery stores and pharmacies where its difficult to stay at least 6 feet apart. The National Academies of Science, Engineering and Medicine issued a report that month that found the available evidence is inconclusive about the degree to which homemade fabric masks may suppress spread of COVID-19 from the wearer to others.

But many public health experts have become convinced of the benefits of wearing homemade masks after seeing what has happened in hospitals, where workers who dont directly work with patients have had to resort to cloth masks, said Dr. Priya Sampathkumar, a critical care and infectious disease specialist at the Mayo Clinic.

When we instituted that, we did see a significant decrease in person-to-person transmission between these workers, she said. So, it definitely works.

Internal hospital data at Duke University suggest universal masking requirements significantly reduces the spread among health care workers, Dr. Sallie Permar, a pediatric infectious disease specialist at Duke. She also cited the emergence of case studies, such as one published in Missouri about a hair salon, where masks were credited with helping 140 clients and six co-workers avoid illness even though two stylists were infected.

Dr. Roger Shapiro, associate professor of immunology and infectious diseases at Harvard T.H. Chan School of Public Health in Boston, said Asian nations including Japan, South Korea and Singapore have proved that social distancing and mask use are effective in controlling the viral outbreak.

If everyone wears masks, this epidemic will go down. Its very simple, Shaprio said in a June 20 call with reporters. Association is not causation, but these [results] are hard to ignore. We really need to be looking to Asia for how to control this.

Dr. Keith Stelter, a family medicine physician in Mankato and president of the Minnesota Medical Association, said some research shows mask-wearing adds an additional 20% protection when used with other pandemic precautions, like social distancing and hand-washing.

Statistically speaking, its a no-brainer, said Dr. Jon Pryor, president of Essentia Healths east market. Masks make a difference. They have been proven to protect us. By wearing a mask you are not making a political statement, you are making a statement that says I care about others.?

False sense of security

Still, some remain skeptical that the quality of evidence for cloth masks is strong.

Dr. Michael Osterholm, director of the University of Minnesotas Center for Infectious Disease Research and Policy, said he is concerned that advocates have oversold the scientific data on cloth masks, giving users a false sense of security.

Distance, distance and distance its the most important risk reduction activity you can do, he said, referring to social distancing of 6 feet or more.

Yet even Osterholm supports using cloth masks. He says there is no harm in wearing one, even if it helps only a little bit, as long as it is worn properly.

After studying news footage showing crowds of people gathered in public in recent weeks, Osterholms research group at the U estimated 26% of people fail to cover their noses when wearing a mask.

Thats like fixing three of the five screen doors on your submarine, he said.

Staff writers Brooks Johnson and Torey Van Oot contributed to this report. 612-673-4779 612-673-4744

2020 the Star Tribune (Minneapolis)

Visit the Star Tribune (Minneapolis) at

Distributed by Tribune Content Agency, LLC.

More here:
Gov. Walz is urged to require Minnesotans to wear masks in COVID-19 fight - msnNOW

Read the Rest...

Nanomaterials and Nanotechnology Market: Analysis and In-depth study on market Size Trends, Emerging Growth Factors and Regional Forecast to 2027 -…

§ July 5th, 2020 § Filed under Nanotechnology Comments Off on Nanomaterials and Nanotechnology Market: Analysis and In-depth study on market Size Trends, Emerging Growth Factors and Regional Forecast to 2027 -…

The Nanomaterials and Nanotechnology market is an intrinsic study of the current status of this business vertical and encompasses a brief synopsis about its segmentation. The report is inclusive of a nearly accurate prediction of the market scenario over the forecast period market size with respect to valuation as sales volume. The study lends focus to the top magnates comprising the competitive landscape of Nanomaterials and Nanotechnology market, as well as the geographical areas where the industry extends its horizons, in magnanimous detail.

The market report, titled Global Nanomaterials and Nanotechnology Market Research Report 2019 By Manufacturers, Product Type, Applications, Region and Forecast to 2025, recently added to the market research repository of details in-depth past and present analytical and statistical data about the global Nanomaterials and Nanotechnology market. The report describes the Nanomaterials and Nanotechnology market in detail in terms of the economic and regulatory factors that are currently shaping the markets growth trajectory, the regional segmentation of the global Nanomaterials and Nanotechnology market, and an analysis of the markets downstream and upstream value and supply chains.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @

The report offers the market growth rate, size, and forecasts at the global level in addition as for the geographic areas: Latin America, Europe, Asia Pacific, North America, and Middle East & Africa. Also, it analyses, roadways and provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading market players within the Nanomaterials and Nanotechnology market. The industry-changing factors for the market segments are explored in this report. This analysis report covers the growth factors of the worldwide market based on end-users.

The key manufacturers covered in this Nanomaterials and Nanotechnology market report:

The key players covered in this study BASF SE Minerals Technologies Inc AMCOL International Liquidia Technologies NanoOpto BioDelivery Sciences International Hosokawa Micron Group Hyperion Catalysis International Incorporated BBI Solutions Cytodiagnostics Goldsol NanoComposix Sigma Aldrich Tanaka Technologies Eastman Kodak Company

Market segment by Type, the product can be split into Carbon Nanotubes Nanoclays Nanofibers Nanosilver Others

Market segment by Application, split into Aerospace Automotive Medical Military Electronics Others

Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America

The study objectives of this report are: To analyze global Nanomaterials and Nanotechnology status, future forecast, growth opportunity, key market and key players. To present the Nanomaterials and Nanotechnology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nanomaterials and Nanotechnology are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]

In accordance with a competitive prospect, this Nanomaterials and Nanotechnology report dispenses a broad array of features essential for measuring the current Nanomaterials and Nanotechnology market performance along with technological advancements, business abstract, strengths and weaknesses of market position and hurdles crossed by the leading Nanomaterials and Nanotechnology market players to gain leading position. Other aspects such as customer base, sales reach, local coverage, production price trends, and production cost layout are also analyzed to bestow accurate rivalry perspective.

Pivotal highlights of Nanomaterials and Nanotechnology market:

The Nanomaterials and Nanotechnology market report includes a brief about the cost analysis, key raw material used, as well as the fluctuating price trends of the war material.

The suppliers of the raw material and their market concentration rate have also been enlisted.

The manufacturing cost structures, encompassing details about the raw material, manufacturing process analysis, as well as labor costs have been enumerated in the study.

Substantial details about the industry chain analysis, downstream buyers, and sourcing strategies have been elucidated.

A separate section has been designated for the analysis of the marketing strategy adopted, as well details about the distributors that are a part of the supply chain.

The report is inclusive of information regarding the channels adopted for the product marketing, marketing channel development trends, pricing and brand strategies, as well as target clientele.

You can Buy This Report from Here @

View original post here:

Nanomaterials and Nanotechnology Market: Analysis and In-depth study on market Size Trends, Emerging Growth Factors and Regional Forecast to 2027 -...

Read the Rest...

Global Nanocoatings For Building And Construction Market with COVID-19 After Effects Analysis by Top Key Players Theta Chemicals, Inframat, Nanogate,…

§ July 5th, 2020 § Filed under Nanotechnology Comments Off on Global Nanocoatings For Building And Construction Market with COVID-19 After Effects Analysis by Top Key Players Theta Chemicals, Inframat, Nanogate,…

Nanocoatings For Building And Construction Industry Overview Competitive Analysis, Regional and Global Analysis, Segment Analysis, Market Forecasts 2026

An updated report on the globalNanocoatings For Building And Construction marketis published by theMarket Research Store. The report study gives you each and every detail about the Nanocoatings For Building And Construction market. It helps you to understand the Nanocoatings For Building And Construction market in a comprehensive way. Some of the industry players that are operating in the Nanocoatings For Building And Construction market includesTheta Chemicals, Inframat, Nanogate, CTC Nanotechnology, Nanophase Technologies, Advenira Enterprises, Tesla NanoCoatings, AdMat Innovations. Each and every organization and association is profiled in detail in the study.

Request Free Sample Copy of Nanocoatings For Building And Construction Market Research Report@

All the contents present in the dossier are updated due to the current outbreak of the pandemic COVID-19. Due to the spread of coronovirus, every market on the global platform is facing challenges. The healthcare sector is also facing challenges owing to the increased demand for the healthcare products around the world. In terms of business, the Nanocoatings For Building And Construction market is facing problems due to lockdown in many of the regions, change in the trading conditions, and upcoming economic crisis.

The Nanocoatings For Building And Construction report starts with the market definition and the market overview. Furthermore, the report showcases the target audience for the Nanocoatings For Building And Construction market. The next section of the report consists of the qualitative information. It consists of the market drivers, hindrances, opportunities, and challenges. The information is updated owing to the current market scenario.

Read Detailed Index of full Research Study at::

The Nanocoatings For Building And Construction market is segmented into{Vapor Deposition, Electroplate, Spraying, Other}; {Building, Infrastructure}and some of the major market segments are also further sub-segmented in order to analyze the market in-depth. The regional information about the Nanocoatings For Building And Construction market is also included. The major regions that are covered in the report include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. The data is not just restricted to regions but country-wise market analysis is also included. The information in the dossier includes statistics about each and every segment. The historical, current, and the forecast data for the segments of the Nanocoatings For Building And Construction market is included. The CAGR of every segment is included, which clarifies the further growth of that segment in the coming years.

Major Advantages for Nanocoatings For Building And Construction Market:

Well-organized description of the international Nanocoatings For Building And Construction market along with the ongoing inclinations and future considerations to reveal the upcoming investment areas. The all-inclusive market feasibility is examined to figure out the profit-making trends to obtain the most powerful foothold in the Nanocoatings For Building And Construction industry. The Nanocoatings For Building And Construction market report covers data which reveal major drivers, constraints, and openings with extensive impact analysis. The current market is quantitatively reviewed from 2019 to 2028 to pinpoint the monetary competency of the global Nanocoatings For Building And Construction market. Last but not least, PORTERS Five Forces Analysis shows the effectiveness of the customers and providers from a global perspective.

If Any Inquiry of Nanocoatings For Building And Construction Report:

See the article here:

Global Nanocoatings For Building And Construction Market with COVID-19 After Effects Analysis by Top Key Players Theta Chemicals, Inframat, Nanogate,...

Read the Rest...

The Economic Impact of Coronavirus on Carbon Nanotube (CNT) Dispersions Market: Soaring Demand Assures Motivated Revenue Share During 2020-2026 -…

§ July 3rd, 2020 § Filed under Nanotech Comments Off on The Economic Impact of Coronavirus on Carbon Nanotube (CNT) Dispersions Market: Soaring Demand Assures Motivated Revenue Share During 2020-2026 -…

Carbon Nanotube (CNT) Dispersions Marketreport provides in-depth COVID19 impact analysis ofMarket Overview, Product Scope, Market Drivers, Trends, Opportunities,Market Driving Force and Market Risks. It also profile the topmost prime manufacturers (Unidym, Nanocyl, Cnano, SouthWest NanoTechnologies, canatu, nanointegris, Toray, Shenzhen Nanotech Port Co. Ltd, Foxconn, Hanao Co., Ltd) are analyzed emphatically by competitive landscape contrast, with respect toPrice, Sales,Capacity, Import, Export, Consumption, Gross, Gross Margin, Revenue and Market Share. Carbon Nanotube (CNT) Dispersions industry breakdown data are shown at the regional level, to show the sales, revenue and growth by regions.Carbon Nanotube (CNT) Dispersions Market describe Carbon Nanotube (CNT) Dispersions Sales Channel,Distributors, Customers, Research Findings and Conclusion, Appendix and Data Source.

Key Target Audience of Carbon Nanotube (CNT) Dispersions Market:Manufacturers of Carbon Nanotube (CNT) Dispersions, Raw material suppliers, Market research and consulting firms, Government bodies such as regulating authorities and policy makers, Organizations, forums and alliances related to Carbon Nanotube (CNT) Dispersions market.

Get Free Sample PDF (including full TOC, Tables and Figures)of Carbon Nanotube (CNT) Dispersions[emailprotected]

In-Depth Qualitative Analyses Include Identification and Investigation Of The Following Aspects:Carbon Nanotube (CNT) Dispersions Market Structure, Growth Drivers, Restraints and Challenges, Emerging Product Trends & Market Opportunities, Porters Fiver Forces.

Summary of Carbon Nanotube (CNT) Dispersions Market:Multi-wall carbon nanotubes are the largest product segment, accounting for more than 92% share of the global carbon nanotubes market in 2015. Multi-wall carbon nanotubes consist of multiple layers of graphite/carbon that are superimposed and rolled one over the other to form a cylindrical and tubular structure.

However, a number of issues, including high costs, inconsistent quality across the supply chain, dispersion and compatibility with matrix materials, and toxicology still need to be addressed. Once these issues are resolved, growth in global CNTs demand is expected to accelerate in the next five years.

Global Carbon Nanotube (CNT) Dispersions market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Carbon Nanotube (CNT) Dispersions.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Carbon Nanotube (CNT) Dispersions market foreach application, including-

Electronics & Semiconductors Advanced Materials Chemical & Polymers Batteries & Capacitors Aerospace & Defense Energy Medical Others

On the basis of product,this report displays the sales volume, revenue (Million USD), product price, market share and growth rate ofeach type, primarily split into-

Single-walled Nanotubes (SWNTs) Double wall Nanotubes Multi-walled Nanotubes (MWNTs)

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]

Important Carbon Nanotube (CNT) Dispersions Market Data Available In This Report:


ResearchMoz Mr. Rohit Bhisey, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email:[emailprotected]

Browse More Reports Visit @

Read the original:

The Economic Impact of Coronavirus on Carbon Nanotube (CNT) Dispersions Market: Soaring Demand Assures Motivated Revenue Share During 2020-2026 -...

Read the Rest...

Ion Sources Market To Witness Stunning Growth To Generate Massive Revenue Forecast to 2026| Hitachi High-Technologies, Evans Analytical Group, Fibics…

§ July 3rd, 2020 § Filed under Nanotech Comments Off on Ion Sources Market To Witness Stunning Growth To Generate Massive Revenue Forecast to 2026| Hitachi High-Technologies, Evans Analytical Group, Fibics…

LOS ANGELES, United States: The all-inclusive, comprehensive report presented here is an intelligent compilation of different types of analysis of the global Ion Sources market. It brings to light some of the very important drivers, restraints, trends, and opportunities expected to influence the growth of the global Ion Sources market. The researchers have provided Porters Five Forces, PESTEL, and absolute dollar opportunity analyses to offer a deep research study of the global Ion Sources market. Furthermore, the report offers a thorough analysis of the competitive landscape and key players operating in the global Ion Sources market. Each segment of the global Ion Sources market is broadly evaluated on the basis of vital factors such as market share and CAGR.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)

The analysts authoring the report have identified leading companies operating in the global Ion Sources market. In the company profiling section, the report has shed light on recent developments, market share, new products, and key strategies of top players of the global Ion Sources market. All of the players profiled in the report have been studied with large focus on their business growth and future plans. The analysts have also provided accurate predictions of future changes in market competition.

Key Players Mentioned in the Global Ion Sources Market Research Report:

Hitachi High-Technologies, Evans Analytical Group, Fibics Incorporated, FEI, Carl Zeiss AG, ZEROK Nanotech, Thermo Fisher Scientific Inc., Intlvac, D-Pace, NanoLab, Tescan, Waters

Global Ion Sources Market Segmentation by Product: Electron Ionization Chemical Ionization Gas Discharge Ion Sources Others

Global Ion Sources Market Segmentation by Application: Mass Spectrometers Optical Emission Spectrometers Particle Accelerators Ion Implanters Others

As part of segmental analysis, the report includes a comprehensive study of product and application segments and near-accurate forecasts of their market growth. Moreover, it provides deeper understanding of the performance of leading segments and gives useful knowledge about their market potential. In addition, the analysts have shown their progress during the forecast period with the help of easy-to-understand graphs and statistical presentations.

For geographical analysis of the global Ion Sources market, the analysts have shed light on critical aspects of key regional markets. Each region is deeply assessed in the geographical market analysis section with large focus on market share, CAGR, and growth potential.

Key questions answered in the report: What is the growth potential of the Ion Sources market? Which product segment will grab a lions share? Which regional market will emerge as a frontrunner in coming years? Which application segment will grow at a robust rate? What are the growth opportunities that may emerge in Ion Sources industry in the years to come? What are the key challenges that the global Ion Sources market may face in future? Which are the leading companies in the global Ion Sources market? Which are the key trends positively impacting the market growth? Which are the growth strategies considered by the players to sustain hold in the global Ion Sources market?

Request for customization in Report:

Table of Content

1 Study Coverage 1.1 Ion Sources Product Introduction 1.2 Key Market Segments in This Study 1.3 Key Manufacturers Covered: Ranking of Global Top Ion Sources Manufacturers by Revenue in 2019 1.4 Market by Type 1.4.1 Global Ion Sources Market Size Growth Rate by Type 1.4.2 Electron Ionization 1.4.3 Chemical Ionization 1.4.4 Gas Discharge Ion Sources 1.4.5 Others 1.5 Market by Application 1.5.1 Global Ion Sources Market Size Growth Rate by Application 1.5.2 Mass Spectrometers 1.5.3 Optical Emission Spectrometers 1.5.4 Particle Accelerators 1.5.5 Ion Implanters 1.5.6 Others 1.6 Coronavirus Disease 2019 (Covid-19): Ion Sources Industry Impact 1.6.1 How the Covid-19 is Affecting the Ion Sources Industry Ion Sources Business Impact Assessment Covid-19 Supply Chain Challenges COVID-19s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Ion Sources Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 Government Measures to Combat Covid-19 Impact Proposal for Ion Sources Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered

2 Executive Summary 2.1 Global Ion Sources Market Size Estimates and Forecasts 2.1.1 Global Ion Sources Revenue Estimates and Forecasts 2015-2026 2.1.2 Global Ion Sources Production Capacity Estimates and Forecasts 2015-2026 2.1.3 Global Ion Sources Production Estimates and Forecasts 2015-2026 2.2 Global Ion Sources Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Analysis of Competitive Landscape 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 2.3.2 Global Ion Sources Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.3.3 Global Ion Sources Manufacturers Geographical Distribution 2.4 Key Trends for Ion Sources Markets & Products 2.5 Primary Interviews with Key Ion Sources Players (Opinion Leaders)

3 Market Size by Manufacturers 3.1 Global Top Ion Sources Manufacturers by Production Capacity 3.1.1 Global Top Ion Sources Manufacturers by Production Capacity (2015-2020) 3.1.2 Global Top Ion Sources Manufacturers by Production (2015-2020) 3.1.3 Global Top Ion Sources Manufacturers Market Share by Production 3.2 Global Top Ion Sources Manufacturers by Revenue 3.2.1 Global Top Ion Sources Manufacturers by Revenue (2015-2020) 3.2.2 Global Top Ion Sources Manufacturers Market Share by Revenue (2015-2020) 3.2.3 Global Top 10 and Top 5 Companies by Ion Sources Revenue in 2019 3.3 Global Ion Sources Price by Manufacturers 3.4 Mergers & Acquisitions, Expansion Plans

4 Ion Sources Production by Regions 4.1 Global Ion Sources Historic Market Facts & Figures by Regions 4.1.1 Global Top Ion Sources Regions by Production (2015-2020) 4.1.2 Global Top Ion Sources Regions by Revenue (2015-2020) 4.2 North America 4.2.1 North America Ion Sources Production (2015-2020) 4.2.2 North America Ion Sources Revenue (2015-2020) 4.2.3 Key Players in North America 4.2.4 North America Ion Sources Import & Export (2015-2020) 4.3 Europe 4.3.1 Europe Ion Sources Production (2015-2020) 4.3.2 Europe Ion Sources Revenue (2015-2020) 4.3.3 Key Players in Europe 4.3.4 Europe Ion Sources Import & Export (2015-2020) 4.4 China 4.4.1 China Ion Sources Production (2015-2020) 4.4.2 China Ion Sources Revenue (2015-2020) 4.4.3 Key Players in China 4.4.4 China Ion Sources Import & Export (2015-2020) 4.5 Japan 4.5.1 Japan Ion Sources Production (2015-2020) 4.5.2 Japan Ion Sources Revenue (2015-2020) 4.5.3 Key Players in Japan 4.5.4 Japan Ion Sources Import & Export (2015-2020)

5 Ion Sources Consumption by Region 5.1 Global Top Ion Sources Regions by Consumption 5.1.1 Global Top Ion Sources Regions by Consumption (2015-2020) 5.1.2 Global Top Ion Sources Regions Market Share by Consumption (2015-2020) 5.2 North America 5.2.1 North America Ion Sources Consumption by Application 5.2.2 North America Ion Sources Consumption by Countries 5.2.3 U.S. 5.2.4 Canada 5.3 Europe 5.3.1 Europe Ion Sources Consumption by Application 5.3.2 Europe Ion Sources Consumption by Countries 5.3.3 Germany 5.3.4 France 5.3.5 U.K. 5.3.6 Italy 5.3.7 Russia 5.4 Asia Pacific 5.4.1 Asia Pacific Ion Sources Consumption by Application 5.4.2 Asia Pacific Ion Sources Consumption by Regions 5.4.3 China 5.4.4 Japan 5.4.5 South Korea 5.4.6 India 5.4.7 Australia 5.4.8 Taiwan 5.4.9 Indonesia 5.4.10 Thailand 5.4.11 Malaysia 5.4.12 Philippines 5.4.13 Vietnam 5.5 Central & South America 5.5.1 Central & South America Ion Sources Consumption by Application 5.5.2 Central & South America Ion Sources Consumption by Country 5.5.3 Mexico 5.5.3 Brazil 5.5.3 Argentina 5.6 Middle East and Africa 5.6.1 Middle East and Africa Ion Sources Consumption by Application 5.6.2 Middle East and Africa Ion Sources Consumption by Countries 5.6.3 Turkey 5.6.4 Saudi Arabia 5.6.5 U.A.E

6 Market Size by Type (2015-2026) 6.1 Global Ion Sources Market Size by Type (2015-2020) 6.1.1 Global Ion Sources Production by Type (2015-2020) 6.1.2 Global Ion Sources Revenue by Type (2015-2020) 6.1.3 Ion Sources Price by Type (2015-2020) 6.2 Global Ion Sources Market Forecast by Type (2021-2026) 6.2.1 Global Ion Sources Production Forecast by Type (2021-2026) 6.2.2 Global Ion Sources Revenue Forecast by Type (2021-2026) 6.2.3 Global Ion Sources Price Forecast by Type (2021-2026) 6.3 Global Ion Sources Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026) 7.2.1 Global Ion Sources Consumption Historic Breakdown by Application (2015-2020) 7.2.2 Global Ion Sources Consumption Forecast by Application (2021-2026)

8 Corporate Profiles 8.1 Hitachi High-Technologies 8.1.1 Hitachi High-Technologies Corporation Information 8.1.2 Hitachi High-Technologies Overview and Its Total Revenue 8.1.3 Hitachi High-Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.1.4 Hitachi High-Technologies Product Description 8.1.5 Hitachi High-Technologies Recent Development 8.2 Evans Analytical Group 8.2.1 Evans Analytical Group Corporation Information 8.2.2 Evans Analytical Group Overview and Its Total Revenue 8.2.3 Evans Analytical Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.2.4 Evans Analytical Group Product Description 8.2.5 Evans Analytical Group Recent Development 8.3 Fibics Incorporated 8.3.1 Fibics Incorporated Corporation Information 8.3.2 Fibics Incorporated Overview and Its Total Revenue 8.3.3 Fibics Incorporated Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.3.4 Fibics Incorporated Product Description 8.3.5 Fibics Incorporated Recent Development 8.4 FEI 8.4.1 FEI Corporation Information 8.4.2 FEI Overview and Its Total Revenue 8.4.3 FEI Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.4.4 FEI Product Description 8.4.5 FEI Recent Development 8.5 Carl Zeiss AG 8.5.1 Carl Zeiss AG Corporation Information 8.5.2 Carl Zeiss AG Overview and Its Total Revenue 8.5.3 Carl Zeiss AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.5.4 Carl Zeiss AG Product Description 8.5.5 Carl Zeiss AG Recent Development 8.6 ZEROK Nanotech 8.6.1 ZEROK Nanotech Corporation Information 8.6.2 ZEROK Nanotech Overview and Its Total Revenue 8.6.3 ZEROK Nanotech Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.6.4 ZEROK Nanotech Product Description 8.6.5 ZEROK Nanotech Recent Development 8.7 Thermo Fisher Scientific Inc. 8.7.1 Thermo Fisher Scientific Inc. Corporation Information 8.7.2 Thermo Fisher Scientific Inc. Overview and Its Total Revenue 8.7.3 Thermo Fisher Scientific Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.7.4 Thermo Fisher Scientific Inc. Product Description 8.7.5 Thermo Fisher Scientific Inc. Recent Development 8.8 Intlvac 8.8.1 Intlvac Corporation Information 8.8.2 Intlvac Overview and Its Total Revenue 8.8.3 Intlvac Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.8.4 Intlvac Product Description 8.8.5 Intlvac Recent Development 8.9 D-Pace 8.9.1 D-Pace Corporation Information 8.9.2 D-Pace Overview and Its Total Revenue 8.9.3 D-Pace Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.9.4 D-Pace Product Description 8.9.5 D-Pace Recent Development 8.10 NanoLab 8.10.1 NanoLab Corporation Information 8.10.2 NanoLab Overview and Its Total Revenue 8.10.3 NanoLab Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.10.4 NanoLab Product Description 8.10.5 NanoLab Recent Development 8.11 Tescan 8.11.1 Tescan Corporation Information 8.11.2 Tescan Overview and Its Total Revenue 8.11.3 Tescan Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.11.4 Tescan Product Description 8.11.5 Tescan Recent Development 8.12 Waters 8.12.1 Waters Corporation Information 8.12.2 Waters Overview and Its Total Revenue 8.12.3 Waters Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.12.4 Waters Product Description 8.12.5 Waters Recent Development

9 Production Forecasts by Regions 9.1 Global Top Ion Sources Regions Forecast by Revenue (2021-2026) 9.2 Global Top Ion Sources Regions Forecast by Production (2021-2026) 9.3 Key Ion Sources Production Regions Forecast 9.3.1 North America 9.3.2 Europe 9.3.3 China 9.3.4 Japan

10 Ion Sources Consumption Forecast by Region 10.1 Global Ion Sources Consumption Forecast by Region (2021-2026) 10.2 North America Ion Sources Consumption Forecast by Region (2021-2026) 10.3 Europe Ion Sources Consumption Forecast by Region (2021-2026) 10.4 Asia Pacific Ion Sources Consumption Forecast by Region (2021-2026) 10.5 Latin America Ion Sources Consumption Forecast by Region (2021-2026) 10.6 Middle East and Africa Ion Sources Consumption Forecast by Region (2021-2026) 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Ion Sources Sales Channels 11.2.2 Ion Sources Distributors 11.3 Ion Sources Customers 12 Market Opportunities & Challenges, Risks and Influences Factors Analysis 12.1 Market Opportunities and Drivers 12.2 Market Challenges 12.3 Market Risks/Restraints 12.4 Porters Five Forces Analysis 13 Key Finding in The Global Ion Sources Study 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

About Us: QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

See the rest here:

Ion Sources Market To Witness Stunning Growth To Generate Massive Revenue Forecast to 2026| Hitachi High-Technologies, Evans Analytical Group, Fibics...

Read the Rest...

Covid-19 Impact: Capacitive Sensors Market to Witness Exponential Rise in Revenue Share during the Forecast Period (2020-2027) – 3rd Watch News

§ July 3rd, 2020 § Filed under Nanotech Comments Off on Covid-19 Impact: Capacitive Sensors Market to Witness Exponential Rise in Revenue Share during the Forecast Period (2020-2027) – 3rd Watch News

The report titled Global Capacitive Sensors Market is one of the most comprehensive and important additions to Crystal Market Research archive of market research studies. It offers detailed research and analysis of key aspects of the global Capacitive Sensors Market. The Industry analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Capacitive Sensors Market. Market members can utilize the examination on market dynamics to design powerful development methodologies and get ready for future challenges beforehand. Each trend of the global Capacitive Sensors Market is carefully analyzed and researched about by the market analysts.

In Order To Request For Free Sample Copy Click @


Market Dynamics:

Each portion of the worldwide Capacitive Sensors market is broadly assessed in the examination study. The segment investigation offered in the report pinpoints key opportunities accessible in the Capacitive Sensors market through driving fragments. The regional study of the Capacitive Sensors market incorporated into the report encourages readers to increase a sound comprehension of the improvement of various geological markets in recent years and also going forth.

Capacitive Sensors Market, By Product Type, Estimates and Forecast (2016-2027)

Capacitive Sensors Market, By End User, Estimates and Forecast (2016-2027)

Geographical Outlook of Capacitive Sensors report covering:

Get Discount of This Precious Report @

Get Customised Research Report:

Contacts Us:-

Sherry | APAC Marketing Division: Level 23-1

Premier Suite, Mont Kiara, 50480 Kuala

Lumpur, Malaysia

E-mail:- [emailprotected]

See the article here:

Covid-19 Impact: Capacitive Sensors Market to Witness Exponential Rise in Revenue Share during the Forecast Period (2020-2027) - 3rd Watch News

Read the Rest...

How Lithium-Ion Batteries Will Continue to Improve – Nanalyze

§ July 3rd, 2020 § Filed under Nanotech Comments Off on How Lithium-Ion Batteries Will Continue to Improve – Nanalyze

Weve recently began the rather interesting exercise of going through and summarizing the more than 1,600 articles published on Nanalyze since we began waxing poetic almost seven years ago exactly. We were surprised to see that when it comes to grid scale storage, flow batteries just never really achieved the traction investors were looking for, with more companies failing than not. On the other hand, lithium batteries have made great progress in powering other new technologies like electric cars, drones, and smartphones.

Lots of banter has been flying around lately regarding battery breakthroughs. The Chinese have developed a million-mile battery, and His Excellency Mr. Elon Musk is hinting at some breakthrough involving supercapacitors thats now expected to be announced in September (thats about six months later than originally anticipated, mainly because of the rona). In the meantime, dozens of startups are working to improve lithium batteries.

A few years ago, we looked at some lithium-ion battery tech startups getting funding, a list which included the below names (disclosed funding in italics):

Lets look at some lithium-ion battery tech startups that have been taking some funding this year along with a bonus a publicly traded stock thats working on improving lithium batteries.

In looking back at all the companies weve looked at that are trying to improve lithium ion batteries, one theme stands out silicon anodes. Welcome to the Era of Supercharged Lithium-Silicon Batteries, was an article published by Wired this past February which puts it simply. Batteries with silicon anodes promise to make devices last more than 20 percent longer on a single charge. Consequently, investors have been pouring money into startups racing to be first-to-market with silicon anodes.

One startup that recently came out of stealth with their own silicon replacement for anodes is ADVANO.

Founded in 2014, New Orleans startup ADVANO has taken in nearly $24 million in funding to solve the notoriously difficult problem of using silicon in place of graphite for battery anodes. The foundation of their technology is an engineered 3D nanostructurethat serves as a graphene replacement. In order to produce this material, they plan to use silicon waste thats a byproduct of manufacturing solar panels or semiconductors. The company came out of stealth last year and is developing their own anode and battery as well.

Backing ADVANO is chemical giant Mitsui along with Peter Thiel and other notable investors who would have had to know about competitors like Nexeon (backed by Invesco and Wacker Chemie, the latter of which recently acquired 25% of the company) and Sila Nanotechnologies (backed by Daimler) who are also developing silicon anodes, and have been doing so for some time. Were not saying theres room for more than one solution, but ultimately one of these three startups has the superior solution. According to the father of the iPod, Tony Faddell, the key challenges with silicon anodes are material expansion, cycle life, cost, and drop-in manufacturing scalability. ADVANO has solved all four, which is why hes a lead investor in the firm.

There are plenty of other competitors in this space, like Amprius, a firm thats developing anodes using silicon nanowires, and took an investment from Airbus last year. The company claims the highest energy density commercial batteries in the industry, though they dont say much about what theyve been up to other than a press release every year or so. The secrecy is understandable given just how much money is pouring into silicon anode startups. Then theres Enevate, a company thats more than doubled their funding since we last looked at them, money thats come from names like Samsung, Lenovo, and LG Chem to develop a battery technology that makes charging electric vehicles as fast as refueling a gas car. In short, there are loads of companies trying to solve the silicon anode puzzle and presumably some big rewards for the winner(s).

One last thing to note on silicon anodes. While researching this piece, we came across an article by Chemical and Engineering News that quotes Lux Research analyst Chloe Holzinger as saying the focus on silicon anodes is temporary, as we expect lithium-metal anodes to take off in the 2030s. In other words, lithium-ion battery improvements are expected to continue for at least a few decades.

Founded in 2006, Fremont, California startup Enovix has taken in just over $191 million in funding to develop a 3D wave array energy storage system for lithium-ion batteries with backing from names like Intel and Qualcomm. Instead of developing a drop-in solution for existing manufacturing processes, Enovix appears to be reinventing the entire manufacturing process along with their own 100% silicon anode thrown in for good measure.

Per the company, Enovix replaces electrode winding in a standard pouch lithium-ion battery production process with proprietary laser patterning and high-speed stacking tools to increase line capacity by 30%. We dont understand what the first part means, but everyone can understand the last part increasing capacity by 30%. The companys latest round of $45 million which closed this past March will be used to complete their fully automated commercial production line by year-end.

Staying on the 3D theme, Israeli startup Addionics has taken in $7 million in funding to develop a patent-protected scalable 3D metal fabrication method they believe will enhance performance, mileage, safety, cost, and charging time of batteries.Instead of messing with battery chemistry, Addionics takes known materials used in the production of batteries and fabricating them into a different 3D structure. An article by InsideEVs provides some more details about the technology and says the company is currently talking with battery manufacturers.

Weve been hearing about how great graphene is for decades now, so were happy to see at least a few companies moving forward with graphene for lithium-ion batteries. If Skeleton Technologies can become a leading supplier of ultracapacitors because of graphene, then why not have a similar success story for lithium batteries?

Founded in 2014, Los Angeles startup Nanotech Energy has taken in nearly $40 million in funding to become (in the companys own words), the worlds top supplier of graphene. As weve talked about before, there are plenty of graphene suppliers, but not enough commercial products that use the stuff at scale. Over the past three years Nanotech Energy has been working on the development of a high-performance, non-flammable battery for Daimler Mercedes hybrid and electric automobiles. In May they closed an oversubscribed Series C for $27.5 million, and within the next year, the company is planning to release an environmentally friendly battery that can charge 18 times faster than anything that is currently available on the market. Theyre not the only company using graphene to improve lithium batteries.

Founded in 2012, Chicago startup NanoGraf Corporation has taken in around $17 million in funding to develop silicon-graphene anode materials enable longer lasting, faster charging batteries. The technology wsa developed, optimized, and patented in collaboration with researchers at Northwestern University and Argonne National Laboratory. The technology utilizes a wet chemistry process that is highly scalable and already proven in a multi ton-scale pilot manufacturing line in Japan. (In 2018, NanoGraf announced a $5.5 million investment partnership with JNC, a Tokyo-based chemical company.)

The technology promises electric vehicles that can travel 50% farther.

On the topic of graphene, note that there are any number of graphite miners cum graphene suppliers that are working miracles with graphene and just need you on board as an investor to make it all happen. Weve seen enough of them fail to know that this isnt something anyone should be investing money in.

Lastly, while researching this article we came across an $83 million publicly traded company called Nano One Materials (NNO:CN) which just announced the development of a coated, single crystal cathode material for lithium ion batteries that is providing up to 4 times improvement in longevity. (These latest innovations are patent pending.) Were excited to hear that, but were not big fans of companies that spend valuable resources on investor relations instead of focusing on their core competency.

In the media section of the companys website, youll find the results of all this IR outreach plenty of lesser-known pundits saying positive things about the company and suggesting that its an opportunity you need to grab before the train leaves to money town choo choo!

Then theres the recent report by Alpha Direct which is listed in the Media section of Nano Ones website. Heres what it says in the fine print of the report.

Any time we see that a publicly-traded firm has decided to go down this path, we recognize it for the red flag that it is and move on. End of story.

Weve seen countless micro caps issue shares ad infinitum while promising that revenues are just around the corner. Theres nothing wrong with this per se, a companys ultimate mandate is to survive. However, if youre a micro-cap company with no revenues thats issuing shares to survive and has been for a while the odds just arent in your favor. You can see for yourself that in 2015 when they did a reverse merger with a mining company shell, Nano One had 44,793,599 shares outstanding. Today, that number sits at 78,739,802. Most investors probably have no idea of how this dilution will affect their investment over time. As we always have, we caution against making investments in companies like Nano One Materials.

The car battery makes up about 30% of the total cost of an electric vehicle, so the goal is to improve performance while maintaining or reducing costs. There are dozens of startups out there trying to improve upon lithium batteries, and weve only covered a handful. Dont forget that Teslas Battery Day in September provided it doesnt get moved again promises us some big news on batteries. All the big producers of lithium batteries arent sitting on their laurels, theyre also working on new ways to improve lithium batteries. Its still anyones race to win.

Here at Nanalyze, we hold the lion's share of our investing dollars in a portfolio of 30 dividend growth stocks. Find out which ones in the Quantigence Dividend Growth Investing report freely available to Nanalyze Premium subscribers.

Originally posted here:

How Lithium-Ion Batteries Will Continue to Improve - Nanalyze

Read the Rest...

Global Carbon Nanomaterials Market is Poised To Achieve Continuing Growth During Forecast Period 2020-2027 – 3rd Watch News

§ July 3rd, 2020 § Filed under Nanomaterials Comments Off on Global Carbon Nanomaterials Market is Poised To Achieve Continuing Growth During Forecast Period 2020-2027 – 3rd Watch News

The Global Carbon Nanomaterials Market report gives a detailed overview of the key market drivers, restraints, and trends and analyzes the way they will affect markets development over the forecast period 2020-2027

This Global Carbon Nanomaterials Industry 2020 report also gives comprehensive insight of , in-depth overview of the competitive landscape of the Carbon Nanomaterials Market, Industry Size, Share, Market Productions, Pricing, Global Revenues 2018-2020 Import-Export Figures & SWOT Analysis, PEST analysis, PORTER analysis and Forecast till 2027

Get/Download Free sample report,(Including COVID19 Impact Analysis, full TOC, Tables and Figures) @,-segment-by-player,-type,-application,-marketing-channel,-and-region/59080#request_sample

Carbon Nanomaterials Market Influencing Factors:

Carbon Nanomaterials Market Forecast (2020-2027):

(Exclusive Offer: Up to 20% discount on this report):- Ask For Discount

The leading players of Carbon Nanomaterials market includes

Hyperion Catalysis Showa Denko NanoIntegris KURARAYLIVING Co.,Ltd. CNano Technology Canatu Hyperion Catalysis International Inc. Arkema SWeNT Toray DuPont Nanocyl Bayer AG

Carbon Nanomaterials Market Segmentation

Type Analysis of Carbon Nanomaterials Market:

Carbon Nanotubes, Carbon Nanofibers Nanocarbon Spheres

Applications Analysis of Carbon Nanomaterials Market:

Chemical Industry Food Industry Pharmaceutical Industry Aerospace Other

Any Quries Or Customization? Do Inquiry Here,-segment-by-player,-type,-application,-marketing-channel,-and-region/59080#inquiry_before_buying

Globally, Carbon Nanomaterials market spread across-

1. North America Country (United States, Canada)

2. South America

3. Asia Country (China, Japan, India, Korea)

4. Europe Country (Germany, UK, France, Italy)

5. Other Country (Middle East, Africa, GCC)

Segment 1. Carbon Nanomaterials Market Overview, Market Scope, Size Estimation, and Market Segmentation.

Segment 2. Carbon Nanomaterials Growth Drivers, Opportunities, Emerging Segments, and Industry Plans and Policies are explained.

Segment 3. Carbon Nanomaterials Industry Chain Analysis Explaining Manufacturing Base, Market Share, Product Type, Upstream Raw Materials Suppliers, and Downstream Buyers Is Covered.

Segment 4. Carbon Nanomaterials segmentation by type explains growth rate , and value from 2015-2020

Segment 5. Carbon Nanomaterials segmentation by application and regions covers consumption, growth rate, market share, price, and gross margin analysis.

Segment 6. Production, Consumption, Import-Export analysis of Carbon Nanomaterials by regions is explained.

Segment 7. Market Status and regional SWOT Analysis, PEST analysis, PORTER analysis are described.

Segment 8. Competitive landscape structure of top Carbon Nanomaterials players, gross margin analysis, price, and production value is specified.

Segment 9. Carbon Nanomaterials market analysis forecast by volume, value, consumption from 2020-2027 is provided for type, application, and region.

Segment 10. Carbon Nanomaterials Market maturity analysis, consumption forecast, feasibility study, and valuable Insight.

For more Information or Browse the complete report @,-segment-by-player,-type,-application,-marketing-channel,-and-region/59080#table_of_contents

Continued here:

Global Carbon Nanomaterials Market is Poised To Achieve Continuing Growth During Forecast Period 2020-2027 - 3rd Watch News

Read the Rest...

« Older Entries Newer Entries »

Page 4«..3456..1020..»